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ABSTRACT
PENALIZED REGRESSIONS FOR VARIABLE SELECTION MODEL, SINGLE
INDEX MODEL AND AN ANALYSIS OF MASS SPECTROMETRY DATA
Yubing Wan
July 30, 2014
The focus of this dissertation is to develop statistical methods, under the frame-
work of penalized regressions, to handle three different problems. The first re-
search topic is to address missing data problem for variable selection models
including elastic net (ENet) method and sparse partial least squares (SPLS). I
proposed a multiple imputation (MI) based weighted ENet (MI-WENet) method
based on the stacked MI data and a weighting scheme for each observation. Nu-
merical simulations were implemented to examine the performance of the MI-
WENet method, and compare it with competing alternatives. I then applied the
MI-WENet method to examine the predictors for the endothelial function charac-
terized by median effective dose and maximum effect in an ex-vivo experiment.
The second topic is to develop monotonic single-index models for assessing drug
interactions. In single-index models, the link function f is unnecessary mono-
tonic. However, in combination drug studies, it is desired to have a monotonic
link function f . I proposed to estimate f by using penalized splines with I-spline
basis. An algorithm for estimating f and the parameter α in the index was de-
veloped. Simulation studies were conducted to examine the performance of the
proposed models in term of accuracy in estimating f and α. Moreover, I applied
vi
the proposed method to examine the drug interaction of two drugs in a real case
study. The third topic was focused on the SPLS and ENet based accelerated failure
time (AFT) models for predicting patient survival time with mass spectrometry
(MS) data. A typical MS data set contains limited number of spectra, while each
spectrum contains tens of thousands of intensity measurements representing an
unknown number of peptide peaks as the key features of interest. Due to the
high dimension and high correlations among features, traditional linear regres-
sion modeling is not applicable. Semi-parametric AFT model with an unspecified
error distribution is a well-accepted approach in survival analysis. To reduce the
bias caused in denoising step, we proposed a nonparametric imputation approach
based on Kaplan-Meier estimator. Numerical simulations and a real case study
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INTRODUCTION
This dissertation work is composed of three different while connected research
projects.
In project I, I dealt with the issue of handling missing values of multiple pre-
dictors and studied its effect on variable selection and prediction. When missing
values in some predictor variables exist, the statistical methods for variable se-
lection and prediction could be challenging. Although multiple imputation (MI)
(Rubin, 1987; Little and Rubin, 1987; 2002) is a universally accepted technique
for solving missing data problem, how to combine the MI results for variable
selection is not very clear because different imputations may result in different
selected variables. The widely applied variable selection methods in the contex-
t of regression include the sparse partial least squares (SPLS) (Chun and Keleş,
2010) and the penalized least squares, e.g. the elastic net (ENet) method (Zou
and Hastie, 2005). We proposed a MI-based weighted elastic net (MI-WENet)
method, which is based on the stacked MI data sets and a weighting scheme in
the regression procedure. In this method, MI accounts for sampling and impu-
tation uncertainty for missing values, and the weight accounts for the observed
information. Extensive numerical simulations were carried out to compare this
MI-WENet method with other competing alternatives, such as the original ENet
and SPLS methods. Moreover, we applied the MI-WENet method to examine the
predictor variables for the endothelium dysfunction that is quantified by median
effective dose (ED50) and maximum effect (Emax) in an ex-vivo acetylcholine-
induced extension and phenylephrine-induced relaxation experiment.
The project II was inspired with the promising development of combination
therapies within the pharmaceutical industry. In the combination drug studies,
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the dose response relationship is often described by a response surface model
(Greco et al., 1995). Denote the response at the combination dose (d1, d2) as y.
A relative potency, say ρ is often used to describe how effective drug 2 is rela-
tive to drug 1. If we assume the dose-response curve for drug 1 is y = f (d1),
then the dose-response curve for drug 2 is f (ρd2). In the case that the two drugs
have no interaction, i.e. the combination is additive, the effect of the combination
dose (d1, d2) can be described by f (d1 + ρd2). If the effect at (d1, d2) is more (or
less) than the effect of drug 1 at dose level d1 + ρd2, we say the combination dose
(d1, d2) is synergetic (or antagonistic) (Lee et al., 2007; Berenbaum, 1989). It is de-
sirable that the response surface model is reduced to a dose-response when only
one drug is applied. In the dose-response studies, the dose response relationship
is often assumed to be monotonic (Kong and Eubank, 2006; Ramsay and Bara-
hamowicz, 1989; Ramsay, 1998). Plummer and Short (1990) and Kong and Lee
(2006) used monotonic parametric models to identify and quantify departures
from additivity. However, the estimates of α can be biased when the parametric
function f is misspecified. To avoid the problem caused by the misspecification
of the function f , we propose the single-index model for assessing drug inter-
actions. We do not assume any specific function form for f . Instead, we only
assume that f is monotonic, and has continuous first and second derivatives. The
function f is estimated by using penalized splines with I-splines as its basis func-
tions, and the monotonicity of the function f is achieved by adding constraints
to the coefficients of I-splines basis functions. (Kong and Eubank, 2006; Ramsay
and Barahamowicz, 1989; Ramsay, 1998). Single-index models have been exten-
sively studied in the statistical literatures (Stoker, 1986; Härdle and Stoker, 1989;
Ichimura, 1993; Yu and Ruppert, 2002). A single-index model could be considered
as an extension of a general linear model by replacing Xα with a nonparametric
function of Xα, f (Xα), where X is a vector of covariates, α is the unknown param-
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eter vector, and f is an unknown univariate link function. Although single-index
models have been well studied, the function f in the model is unnecessary mono-
tonic. We developed an algorithm for estimating the monotonic link function f
and the parameter α in the single-index model. Simulation studies are carried
out to examine the performance of the proposed model in term of accuracy in
estimating f and α. In addition, we apply the proposed monotonic single-index
method to examine the drug interaction of two drugs in a case study given by
Harbron (2010).
Mass spectrometry (MS) data has been applied extensively and demonstrated
great advantage in diagnosing and identifying proteomic biological markers to
the discovery of key proteins and protein profiles associated with various types
of diseases (Stoeckli et al., 2001; Adam et al., 2002; Aebersold and Mann, 2003; Rai
and Chan, 2004; Datta et al., 2008; Datta and Pihur, 2010). Matrix-assisted laser
desorption/ionization imaging mass spectrometry (MALDI-IMS) is a prosperous
molecular technology that acquires information from intact proteins directly from
thin sections of tissue. A typical MALDI-IMS data set contains hundreds of spec-
tra, and each spectrum contains tens of thousands of intensity measurements
representing an unknown number of protein/peptide peaks which are the key
features of interest. Although some basic preprocesses like denoising and peak
detection may identify some peaks for interested features, there are still hundreds
or thousands of retained potentially important features which could be useful for
the predictive modeling. Due to the high dimension as well as some high corre-
lations among features, traditional linear regression modeling of survival times
with proteomic features is not applicable. In order to predict patient survival
using a predictive statistical model, one needs to consider dimension reduction
and important feature selection on top of basic pre-processing of mass spectrom-
etry data very carefully. Semi-parametric accelerated failure time (AFT) model
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with an unspecified error distribution is a flexible and well-accepted approach in
survival analysis. As far as we know, there are only a few publications on em-
ployment of the AFT model in high dimensional data setting, which mostly use
the microarray platforms. Mostajabi et al. (2012) compared the performances of
four relatively recent latent factor and/or penalized regression techniques (PLS,
SPLS, LASSO and elastic net) in fitting AFT models based on high dimensional
regressions, specifically to predict patient survival times using high dimensional
mass spectrometry data. In project III, I focused on two popular techniques that
performed best in the study of Mostajabi et al. (2012), namely SPLS and elastic net,
to fit AFT models for predicting patient survivals. For identifying the subsets of
features important for prediction analysis, some preprocessing steps like binning,
standardizing, baseline correcting, and peak identifying are usually necessary.
Depending on analysis goals, the preprocessing procedures can be different and
complex in different literatures (Datta et al., 2007; Antoniadis et al., 2010; Morris
et al., 2005; Mostajabi et al., 2012; Ndukum et al., 2011). In our methodology,
we performed three basic preprocessing steps as baseline subtraction, alignment,
and denoising to maintain as much information as possible before applying the
AFT models in the subsequent survival analysis. To ensure the features used in
analysis corresponding to real peaks, we applied a hard thresholding algorith-
m similar as in Datta et al. (2007); Ndukum et al. (2011); Mostajabi et al. (2012)
to remove noise signals from the MS data. The denoising step ensures that the
features used in analysis corresponding to real peaks. However, during the de-
noising, the intensities under thresholds are all considered as missing and are
usually replaced with zeroes artificially. It is desirable to find a proper approach
to retain sufficient true signals meanwhile reduce the bias for the subsequent pre-
dictive modeling analysis effectively. To solve this missing problem, we proposed
a nonparametric imputation approach based on Kaplan-Meier estimator by con-
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sidering the aligned intensities across all spectra as life times. We compared the
predictive performance for the patient survival times with and without the impu-
tation of the left censored peaks. Additionally, we compared different penalized
regression schemes along with the AFT models to predict the patient survival
times.
We anticipate that this dissertation research will significantly advance the area
of variable selection and outcome prediction (dose response and patient survival
time), with various types of predicting data, e.g. covariates with missing data and
high dimensional mass spectrometry data.
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TOPIC I: VARIABLE SELECTION MODELS BASED ON MULTIPLE
IMPUTATION WITH APPLICATION FOR PREDICTING MEDIAN
EFFECTIVE DOSE AND MAXIMUM EFFECT
2.1 Introduction
Missing data is a common problem in various settings including clinical trials,
animal studies, and survey sampling (Rubin, 1987; Little and Rubin, 1987; 2002).
When analyzing data with missing values, a straightforward strategy is to con-
duct a complete case analysis, where the observations with any missing values are
ignored. This approach is simple yet ignores the possible differences between the
complete cases and incomplete cases that may result in a substantial bias when the
subjects with complete observations are not a random sub-sample of all subjects
(Rubin, 1987). The complete case analysis also may lose information, and thus,
results in incorrect inferences (Rubin, 1987; Van Buuren, 2012). Because experi-
ments in medical research are usually expensive, the need for adequate handling
of missing data is a constantly recognized source of concern (Wood et al., 2004).
Instead of the complete case analysis, a more sophisticated approach called sin-
gle imputation is used to impute the missing values with plausible values, and
then statistical analyses are carried out on the imputed data set. However, the
single imputation method ignores the uncertainty of imputation on the missing
values that may lead to the underestimation of variances and the distortion of
the correlation structure of the data. Therefore, simple single imputation is usu-
ally not recommended (Rubin, 1987; Little and Rubin, 1987; 2002; Van Buuren,
2012). Multiple imputation (MI) has gradually become a more well-accepted
imputation-based statistical technique for handling missing data since the pub-
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lication of Rubin’s pioneering work for nonresponses in survey (Rubin, 1987).
MI procedure involves imputing each missing value with M (> 1) independent
plausible values, and then applying the standard analysis to each imputed data
set. The final estimates of the parameters and their variances are obtained from
the M sets of estimates using Rubin’s rules, with accounting for the uncertainty
among multiple imputations (Little and Rubin, 2002; Van Buuren, 2012). The ob-
jective of MI method is not to predict missing values as close as possible to the
true values but to handle missing data so that valid statistical inferences can be
made (Little and Rubin, 2002; Van Buuren, 2012). Rubin’s rules have become the
gold standard when data are missing at random (Wood et al., 2005; Van Buuren
et al., 1999; Cohen et al., 2003). By the definition of Little and Rubin in (Rubin,
1987), the three general types of missing mechanism are: 1) missing complete at
random (MCAR); 2) missing at random (MAR); and, 3) not missing at random
(NMAR) (Rubin, 1987; Little and Rubin, 1987; 2002). Standard implementation of
MI relies on an assumption that missing data are either MCAR or MAR, while the
MI procedure may also be extended to the cases where missing data are NMAR
(Van Buuren et al., 1999; Wood et al., 2008; Carpenter et al., 2007).
Variable selection is increasingly important in modern data analysis. Many
techniques, such as the least absolute shrinkage and selection operator (LASSO)
(Tibshirani, 1996), the elastic net (ENet) (Zou and Hastie, 2005), and the sparse
partial least squares (SPLS) (Chun and Keleş, 2010), have been developed to select
important variables that are associated with outcome variables. LASSO mini-
mizes the restricted least squares with the constraint on the absolute values of
the parameters (i.e., L1 norm), and ENet minimizes the constrained least squares
with the constraint on the combination of the absolute and the squared values of
parameters (Tibshirani, 1996; Zou and Hastie, 2005; Hastie et al., 2001). SPLS max-
imizes the correlation between outcome variables and the linear combinations of
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predictor variables (covariates) with constraints on the L1 norm of the parameters
(Chun and Keleş, 2010). The constraint for LASSO can be considered as a special
case of the ENet, and several studies have shown that ENet performs better than
LASSO (Zou and Hastie, 2005). These methods have assumed that the observa-
tions in the data set are complete. How to apply these variable selection methods
to the situation when there are missing values is an important yet unresolved
problem.
Several approaches to combine the variable selection methods with MI tech-
niques have been proposed recently (Wood et al., 2008; Heymans et al., 2007; Chen
and Wang, 2013). Wood et al. proposed a “stacked” approach in (Wood et al.,
2008) by combining the multiply imputed data sets into one and using a weight-
ing scheme to account for the fraction of missing data in each predictor variable.
However, the variable selection method used by them was the classical backward
stepwise selection approach. Heymans et al. developed and tested a methodolo-
gy combining MI with bootstrapping techniques for studying prognostic variable
selection (Heymans et al., 2007). Chen and Wang proposed a MI-LASSO vari-
able selection method as an extension of the LASSO method to MI-based data,
which is, to the best of our knowledge, the only work combining the penalized
least squares method with MI-based data (Chen and Wang, 2013). In the work
(Chen and Wang, 2013), the observations with missing values and those without
missing values are treated with equal importance. In this chapter, I proposed a
MI-based weighted ENet (MI-WENet) method as an extension of the ENet to the
stacked multiple imputed data, with a weight accounting for the proportion of
the observed information for each observation. The cyclical coordinate descent
methods (Friedman et al., 2010) are applied to minimize the weighted penalized
least squares associated with the MI-WENet variable selection method.
To describe the new approach, in Section 2.2, I first review the two most pop-
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ular variable selection methods: SPLS and ENet, and then propose the MI-based
SPLS (MI-SPLS) and the MI-based weighted ENet (MI-WENet) for analyzing data
with missing values. In Section 2.3, I carry out extensive numerical simulations to
evaluate the performance of the proposed methods, and compare the performance
of the proposed methods with the other competing methods. For Section 2.4, I
apply the proposed MI-WENet method to examine the predictor variables for
the maximum effect and the median effective dose in an ex-vivo phenylephrine-
induced extension and acetylcholine-induced relaxation experiment study. Final-
ly, I provide a discussion of the pros and cons of our current approach in Section
2.5.
2.2 Methods
Let Yi denote the outcome variable and Xij be the jth predictor variable (j =
1, ..., p) for the ith subject (i = 1, ..., n). Without loss of generality, I assume that
Yi and Xij are standardized to have zero mean and unit standard deviation. For





Xijβ j + εi = Xiβ + εi, i = 1, ..., n, (2.1)
where the regression coefficients β = (β1, ..., βp)T are unknown parameters to
be estimated, and the error term εi are independently identically distributed as
N(0, σ2).
2.2.1 Review of SPLS and ENet
The sparse partial least squares regression (SPLS) (Chun and Keleş, 2010) is
an extension of partial least squares regression (PLS) (Wold, 1985) to achieve si-
multaneous dimension reduction and variable selection. The PLS begins with
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calculating the first latent direction vector t1 as Xβ̂(1), where β̂(1) is obtained by
maximizing the correlation between the response variable Y and the linear com-
bination of covariates, Xβ, i.e.,





, subject to βTβ = 1. (2.2)
Suppose the kth (k ≥ 1) direction vector, tk = Xβ̂(k), has been obtained. Denote
T = (t1, t2, ..., tk) and MT = I − T(TTT)−1TT, the (k + 1)th direction vector can be
obtained by solving (2.2), with Y replaced by its orthogonal projection onto the
complementary of the column space of the known direction vectors T, i.e., replac-
ing Y by MTY. This process is repeated to obtain a small number of direction
vectors. Regressing the original Y on those direction vectors result in a relation-
ship between Y and X due to each direction vector is a linear combination of the
covariates X. PLS has become a very popular tool in the field of chemometrics
and bioinformatics (Datta, 2001; Pihur et al., 2008). The SPLS achieves the sparsity
of the coefficients on X by adding the L1 constraints on β (Chun and Keleş, 2010).











|β j|. The L1 constraint is added to obtain each direction vec-
tor (Chun and Keleş, 2010). SPLS obtains good performance in prediction and
variable selection by producing sparse linear combinations of the original predic-
tors, and is especially applicable when p is much greater than n (Chun and Keleş,
2010).
The elastic net (ENet) (Zou and Hastie, 2005) is a widely applied regulation
and variable selection method. The ENet estimator is obtained by undoing the
10
shrinkage for the naïve elastic net estimator that is obtained by minimizing the
penalized least squares






(yi − β0 − xTi β)2 + λPα(β), (2.4)
where














Here Pα is the elastic net penalty that is a compromise between the ridge regres-
sion penalty (α = 0) (Hoerl and Kennard, 1970) and the LASSO penalty (α = 1)
(Tibshirani, 1996). Ridge regression is known to shrink the coefficients of correlat-
ed predictor variables, allowing them to borrow strength from each other (Hoerl
and Kennard, 1970; Hastie et al., 2001). The elastic net penalty with α = 1− ε, for
some small ε > 0, performs much like the LASSO but removes any degeneracies
and wild behavior caused by extreme correlations (Friedman et al., 2010). For a
given λ, as α increases from 0 to 1, the sparsity of the solution to (4.4), i.e., the
number of coefficients being zero, increases monotonically from 0 to the spar-
sity of the LASSO solution. The naïve elastic net estimator obtained from (4.4)
and (4.5) does not perform satisfactorily (Zou and Hastie, 2005), while the elastic
net estimator that undoes the shrinkage for the naïve elastic net, performs much
better even compared with LASSO and ridge regression. The ENet estimator is
obtained as
β̂(ENet) = (1 + λ(1− α)) β̂(naß̈ve ENet). (2.6)
The ENet penalty is particularly useful in the cases that p is greater than n and
there are many correlated predictors (Zou and Hastie, 2005), which has also been
shown in our simulation studies.
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2.2.2 MI-based SPLS and MI-based Weighted ENet
Both the SPLS and ENet methods assume that all covariates and outcome
variables are fully observed. In the cases that there are missing values, Rubin’s
rules provide a general framework to handle missing problems provided missing
data are missing at random (MAR) or missing completely at random (MCAR)
(Rubin, 1987; Little and Rubin, 1987; 2002; Van Buuren, 2012). However, Rubin’s
rules can not be directly applied to SPLS or ENet, because the variables selected
for one imputed data set may be quite different from those based on another
imputed data set. To the best of our knowledge, there is no standard rule to
combine the selected variables resulted from different imputed data sets (Cohen
et al., 2003; Wood et al., 2008; Chen and Wang, 2013; Schomaker and Heumann,
2013).
To overcome the shortcoming in combining the multiple results from MI data,
we propose to select variables based on the stacked MI data. To be specific, let
us assume that the outcome variable is fully observed, but the predictor variables
may have some missing values. The missing values in the variables are imputed
M times independently to generate M imputed data sets. We denote the mth im-
puted data set as (yi; x
(m)




i=1, for m = 1, ..., M, where x
(m)
ij is the value of
the jth predictor variable for the ith subject in the mth imputed data set. If Xij is
observed, then we have x(1)ij = ... = x
(M)
ij = xij; and if Xij is missing, then x
(m)
ij may
take different values in each imputation. Popular softwares for implementing MI
procedure include the R-packages mice (Van Buuren and Groothuis-Oudshoorn,
2011) and mi (Su et al., 2011), the SAS software IVEware (Raghunathan et al.,
2001), and a module named MULTIPLE IMPUTATION in SPSS. In the simulation
studies, we applied the R-package mice that is based on the sequential regression
MI, i.e. the multivariate imputation by chained equations, to impute missing da-
ta (Van Buuren and Groothuis-Oudshoorn, 2011; Raghunathan et al., 2001). In
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applying the R-package mice, users are allowed to specify the conditional distri-
bution of each variable on the other variables in the data. The imputation was
carried out based on the specified conditional distribution for the missing vari-
ables (Van Buuren and Groothuis-Oudshoorn, 2011).
Once M imputed data sets are obtained, one may stack the M imputed data
sets as a large complete data set having M× n observations. SPLS and ENet can
be directly applied to this single stacked data set. These approaches are called MI-
based SPLS (MI-SPLS) and MI-based ENet (MI-ENet), respectively. In general, the
estimates based on the stacked MI data are unbiased if the estimates based on a
single data set are unbiased, while the standard errors based on the stacked MI
data will be under-estimated if they can be estimated (Cohen et al., 2003). For the
MI-ENet method, a simple way to correct the underestimated errors is to apply a
weight to each observation. Denote this weight by wi for subject i. For the stacked
M imputed data sets, one could assign wi = 1/M thus the overall weight for a
subject is 1. This weighting scheme puts the same weight for each subject and
ignores the degree of missing information. A more legitimate way is to assign
weights according to the quality of the observed information. If a subject has
more missing predictor variables, the weight assigned to the subject should be
smaller. We propose to assign the weight wi = fi/M, where fi is the fraction of
observed values for subject i, i.e., the ratio of number of observed variables for the
subject i to the total number of predictor variables p. This approach is named as
MI-based weighted ENet (MI-WENet) method.
















where β = (β1, ..., βp). The penalty here is the same as the ENet penalty in (4.4).
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I propose to standardize each predictor variable first based on the available data,
then carry out the multiple imputation to get M imputed data sets. In the stacked
data, the values for each variable may not have mean zero and variance 1 and the
intercept may not be the mean of the observed responses anymore. Thus β0 needs
to be estimated in the same manner as the other regression parameters β. By
avoiding any re-standardization in the stacked data, ∑Mm=1 wi
(






yi − β0 − xTi β
)2, if there is no missing predictor variable for subject
i. Thus, the objective function is reduced exactly to the standard ENet, when there
is no missing value at all in the original data.
Denote the objective function (2.7) as R(β0, β). To solve for (β0, β), a coordinate
descent method can be applied (Friedman et al., 2010). Assuming the current
estimated β̃0 and β̃ are known, we wish to update β̃ j as β̃ j + ∆β j by partially
optimizing R(β0, β) with respect to β j (j = 0, 1, ..., p). Note that the gradient for






















+ λ (1− α)
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where (β0, β) = (β̃0, β̃). Set
∂R(β0,β)
∂∆β j





















ij + λ(1− α)
, (2.9)
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where (β0, β) = (β̃0, β̃). Then β j is updated as follows:
β̃ j
(new)

















































ij + λ(1− α)
,
(2.10)
where (β0, β) = (β̃0, β̃), and S(z, γ) is the soft-thresholding operator with value
sign(z) (|z| − γ)+ =

z− γ if z > 0 and γ < |z|
z + γ if z < 0 and γ < |z|
0 if γ ≥ |z|.
To reduce imputation burden, for a given multiple imputed stacked data set and


























ij′ , for 0 ≤ j ≤ j
′ ≤ p.
Here x(m)ij is set to 1 for j = 0. Suppose that β̃ j
(old)
(j = 0, 1, ..., p) are the available






XYj −∑l<j XXjl β̃l
(new) −∑l>j XXjl β̃l
(old), λα
)
XXjj + λ(1− α)
. (2.11)
The procedure is repeated until convergence to get the estimates for β j (j =
0, 1, ..., p). These estimates are similar to the naïve ENet estimates (Zou and Hastie,
2005), which can be obtained by a truncation at λα and a shrinkage with a factor
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XXjj + λ(1− α) for β j. A better estimate that undoes the shrinkage is obtained by
β̂ j(weighted ENet) =
(
XXjj + λ(1− α)
)
β̂ j(weighted naive ENet). (2.12)
The weighted ENet estimates in (2.12) are used in the simulations in Section 2.3
and the case study in Section 2.4, and performs well in both variable selection and
prediction.
In the present work, I applied 10-fold cross validation method to select the
tuning parameters α and λ. Here α ∈ (0, 1), and λ > 0. Because (α, λ) determines
the soft-threshold boundary, I start with a sequence grid value for α. For each
fixed α, I compute the solution for a decreasing sequence of values for λ starting




and set λmin = ελmax with ε = 0.001. I construct a sequence of λ values decreas-
ing from λmax to λmin on the log-scale. The pair of (α, λ) is chosen such that the
cross validation error is minimized.
2.3 Simulation
In this section, I design different simulation schemes to examine the perfor-
mance of the proposed MI-WENet method and compare it with the other meth-
ods, such as MI-SPLS and MI-ENet. The different simulation scenarios are report-




In the simulation studies, I assume that the underlying model is known and
has the form of Yi = Xiβ + εi, for i = 1, ..., n, where Xi = (Xi,1, ..., Xi,p), β =
(β1, ..., βp)T, and εi ∼ N(0, σ2). The predictor variables for each subject were
generated from a multivariate normal distribution with mean zero and a covari-
ance matrix Σ. σ was set as the value such that the signal to noise ratio is 2, i.e.,√
βTΣβ/σ = 2.
Simulation scenarios were designed based on various assumptions of sam-
ple size n, number of predictor variables p, missing mechanism, missing pattern
and correlation structure of the predictor variables. Correlation structure for the
predictor variables of the ith subject (i = 1, ..., n) was tested under three specifica-
tions: 1) compound symmetry with low correlation, i.e., corr(Xi,j, Xi,j′) = 0.1; 2)
compound symmetry with medium correlation, i.e., corr(Xi,j, Xi,j′) = 0.5; and 3)
first-order autoregressive (AR(1)), i.e., corr(Xi,j, Xi,j′) = 0.8|j−j
′|, for j, j′ = 1, ..., p
and j 6= j′, respectively. I set the homogenous variances as 1 for all Xi,j, so the
covariance matrix Σ was same as the correlation matrix. Under each specification,
I induced missing values under the MCAR and MAR mechanisms, respectively;
and for each missing mechanism, missing values were generated with indepen-
dent and monotone missing patterns, respectively. In total, 17 scenarios were test-
ed in our simulations, which I believe have covered most situations in practical
application. The independent missing pattern means that the missing observa-
tions for different variables are independent, and the monotone missing pattern
is that a missing observation in xij (where i is the subject index, and j is the
variable index) implies that all observations xij′ for j ≤ j′ ≤ p are missing.
For each scenario with fixed n, p, Σ, missing mechanism and missing pattern,
the following steps are carried out:
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1. Generate fully observed predictor variables for Xi (i = 1, ..., n).
2. Generate the outcome variable for Yi from the underlying model Yi = Xiβ +
εi (i = 1, ..., n), where εi ∼ N(0, σ2).
3. Independently generate test data set (xt, yt) (t = 1, ..., nt) by repeating steps 1
& 2, where the sample size nt is larger than n (nt = 1000 in our simulations).
4. Fit the full data set that has a sample size n and has been generated in steps 1
& 2 by using SPLS and ENet, respectively (see the rows named as Full-SPLS
and Full-ENet in Tables 2.1-2.3).
5. Induce missing values for the predictor variables according to each pre-
specified missing mechanism and missing pattern.
6. Fit the data set including complete cases only by using SPLS and ENet,
respectively (see the rows named as CC-SPLS and CC-ENet in Tables 2.1-
2.3).
7. Impute missing values M times (M=5), and stack the M imputed data sets
into an enlarged one.
8. Perform SPLS, ENet and WENet based on the first single imputed data set
(see the rows named SI-SPLS, SI-ENet and SI-WENet in Tables 2.1-2.3), and
based on the stacked data set (see the rows named MI-SPLS, MI-ENet and
MI-WENet in Tables 2.1-2.3).
9. Repeat Steps 1-8 100 times, and summarize the averaged key performance
measures of each method.
The key performance measures for each method under each simulation sce-
nario are predicted mean squared error (PMSE), mean squared error (MSE), sen-
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(yt − xt β̂)2,
where xt and yt are fully observed independent test data generated in Step 3, and
β̂ is the estimate of the underlying regression parameter β for each model. PMSE
is obtained by averaging the predicted errors on a large number of observations,
where I have set nt as 1000. The MSE is defined as
MSE = (β̂− β)TΣ(β̂− β),
where β̂ and β are the same as for PMSE, Lower values of PMSE and MSE are
desirable. The sensitivity is defined as the fraction of variables selected among
those whose coefficients are not zero in the underlying model, and the specificity
is defined as the fraction of variables not selected among those whose coefficients
are zeros in the underlying model. Larger sensitivity and specificity indicate a
better performance.
To examine the performance of different methods, I first fixed p = 12, n = 50
and β = (3, 1.5, 0, 0, 2, 0, 3, 1.5, 0, 0, 2, 0)T, and I considered the combinations of
different missing mechanism (MCAR and MAR), different missing pattern (in-
dependent and monotone) and different correlation structure for the predictor
variables. Under the MCAR scheme, the independent missing pattern was gener-
ated by independently removing 16% of the observations from each of the first 6
predictor variables, which resulted in around 50% observations containing miss-
ing values; the monotone missing pattern was generated by first inducing missing
values to the 8% of randomly sampled observations from the 1st to 6th predictors,
and then repeatedly adding missing values to another 8% randomly sampled ob-
servations from the 2nd to 6th, 3rd to 6th, 4th to 6th, 5th to 6th, and the 6th only
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predictor variables, which eventually resulted in 48% subjects containing missing
values. The simulation results for MCAR, with different missing patterns and
different correlation structures for the predictor variables, are reported in Table
2.1. For MAR, missing values were induced by the following logistic regression
model:
logit{Pr(Xij(m) is missing|Xij(c) , Yi)} = Xij(c) + Yi, for i = 1, ..., n. (2.13)
Here j(m) = 1, ..., p1 are indices for the predictor variables in which missing values
are to be induced, and j(c) = p1 + j(m) are indexes for the completely observed
predictor variables. When p equals to 12, p1 is set as 6. For independent missing
pattern, the procedure to generate missing values was the same as in the MCAR
cases, except that the 16% removed observations for each of the 6 missing predic-
tor variables were selected by the highest probabilities calculated from the logistic
model (2.13). For monotone missing pattern, we applied the logistic model (2.13)
to the whole data set first, and removed 8% observations from the 1st to 6th predic-
tor variables according to the missing probabilities for the 1st predictor variable.
We then applied the logistic model (2.13) to the remaining data set with complete
cases only, and removed 8% additional observations from the 2nd to 6th predictor
variables according to the missing probabilities of the 2nd predictor variable. Re-
peating above procedure until 8% additional observations were removed for the
6th predictor variable only, resulted in 48% subjects containing missing values in
total. The corresponding simulation results for MAR are reported in Table 2.2.
I also conducted simulations with different combinations of p and n, under
the specification of monotone MAR and AR(1) correlation structure, so that the
performance of different methods with large p and small n (say p = 24, 48, and
60, with n fixed at 50) and with small p and large n (say n = 50, 100, and 200,
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with p fixed at 12) can be examined. Here, when p > 12, the β in the underlying
models were set as the repetitions of (3, 1.5, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0). The procedures
for generating monotone MAR missing values were similar as when p = 12 and
n = 50. In the cases when p = 24 and p = 48, p1 in (2.13) were set as p/2, and the
the percentages of missing values in each iteration were controlled at 4% and 2%,
respectively. When p = 60, p1 was set as 24 and the percentage of missing value
in each iteration was controlled at 2%. The total missing percentage was fixed at
48% under each scenario. The corresponding simulation results are reported in
Table 2.3.
The number of simulation runs is 100 in Tables 2.1-2.3. To examine whether a
large number of simulation runs impacts the simulation results, I carried out the
simulations with 500 runs for each scenario showed in Table 2.3. The correspond-
ing results are reported in Table 2.4.
2.3.2 Simulation Results
The results for MCAR with different missing patterns and different correla-
tions for X are summarized in Table 2.1, and results for MAR are summarized
in Table 2.2. The results for MCAR (Table 2.1) and MAR (Table 2.2) explain con-
sistent improvement in the estimation and prediction errors using the MI-WENet
procedure compared to others. From Tables 2.1 and 2.2, we see that: (1) Full-ENet
is consistently having lower PMSE and MSE than those from Full-SPLS. When
correlations of X are low, Full-ENet has both higher sensitivity and specificity
compared to Full-SPLS; when correlations of X are medium to high, Full-ENet
has similar or a little lower sensitivity (within 12%), while the specificity is around
30% higher than those from Full-SPLS, indicating that the ENet method has better
performances than the SPLS method for the variable selection and prediction in
our simulations. (2) Based on complete cases analysis, both SPLS and ENet (CC-
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SPLS and CC-ENet) methods have much higher PMSE and MSE than all other
imputation based methods; the sensitivity for CC-ENet dropped 30%-50% com-
pared to the Full-ENet, and the specificity for CC-SPLS are generally low. All
these measurements indicate that CC-SPLS and CC-ENet are not recommended.
(3) MI-SPLS has a high sensitivity but the specificity is at least 30% lower than
MI-WENet, indicating that MI-SPLS would select more variables of those should
not be selected. (4) In all the tested simulation scenarios, the MI-based weighted
ENet (MI-WENet) method generally obtains the lowest PMSE and MSE among
all competing imputation methods considered here with an exception in Table
2.1. That is, for the independent MCAR case when the correlations are following
an AR(1) process, the PMSE and MSE for MI-WEnet are slightly larger than the
other imputation based Enet method. The sensitivity and specificity of the MI-
WENet is always close to the full-ENet model. Opposed to that, other imputed
ENet models gain sensitivity with a significant loss in specificity compared to the
full-ENet model. MI-WENet also maintains a reasonable sensitivity and speci-
ficity across all the simulation scenarios. This demonstrates that the MI-WENet
method outperforms all the other methods.
Table 2.3 displays the results based on different combinations of p and n, un-
der the specification of monotone MAR and AR(1) correlation structure. The first
column in Table 2.3 shows the performance of different methods for fixed p = 12,
when n increases, say n = 50, 100, and 200. The results demonstrate that: as n
increases, (1) the PMSE and MSE for each method decreases, which means that
the prediction becomes more accurate as n goes larger; (2) the sensitivity increas-
es, indicating that as n increases, the percentage of correctly selected variables
increases; (3) the specificity stays almost the same, indicating that the sample
size does not impact the percentage of correctly rejected variables effectively; (4)
among all the imputation methods, the MI-WENet method has the best perfor-
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Table 2.1: Simulation results for missing complete at random (MCAR) scenarios
with different missing patterns (independent and monotone) and different corre-
lation structures (compound symmetry with low correlation, compound symme-
try with medium correlation and first-order autoregressive (AR(1))) for p = 12
and n = 50.
Independent MCAR Monotone MCAR
PMSE MSE SENS SPEC PMSE MSE SENS SPEC
Low correlation: corr(Xi,j, Xi,j′) = 0.1
Full-SPLS 14.72 3.52 97.2 67.0 15.05 3.96 95.7 70.2
CC-SPLS 28.84 15.34 80.7 47.7 22.08 10.23 84.5 52.0
SI-SPLS 17.72 6.20 91.7 60.3 18.64 7.21 86.8 70.0
MI-SPLS 16.10 4.68 98.3 36.5 16.59 5.24 98.7 42.5
Full-ENet 13.98 2.83 97.7 74.0 14.28 3.07 97.2 74.7
CC-ENet 30.27 18.51 52.5 87.5 21.99 10.47 68.8 89.3
SI-ENet 15.85 4.61 94.5 71.5 17.18 5.96 89.0 75.3
MI-ENet 15.43 4.22 96.3 71.7 16.38 5.16 94.8 72.2
SI-WENet 15.70 4.45 94.5 74.0 16.56 5.29 91.8 75.7
MI-WENet 15.34 4.14 96.0 74.8 15.90 4.66 94.0 72.8
Medium correlation: corr(Xi,j, Xi,j′) = 0.5
Full-SPLS 32.86 7.60 90.8 41.0 33.30 7.87 86.5 44.3
CC-SPLS 44.56 17.55 81.5 34.5 37.40 11.01 86.8 31.2
SI-SPLS 34.06 8.76 88.5 36.5 34.76 9.25 86.8 40.0
MI-SPLS 33.98 8.28 93.8 23.2 34.28 8.73 91.5 32.2
Full-ENet 30.63 5.67 87.3 71.7 30.99 5.84 86.0 71.5
CC-ENet 58.10 33.02 33.8 84.0 50.03 24.86 42.7 86.0
SI-ENet 32.45 7.42 82.5 66.2 33.18 8.10 77.0 69.0
MI-ENet 31.72 6.67 84.8 68.2 31.99 6.93 81.8 69.2
SI-WENet 32.00 6.95 83.5 69.7 32.73 7.60 79.3 70.8
MI-WENet 31.35 6.35 86.7 68.2 32.01 6.87 81.8 70.3
AR(1) correlation: corr(Xi,j, Xi,j′) = 0.8|j−j
′|
Full-SPLS 27.77 5.91 87.7 28.3 27.93 6.00 88.3 30.2
CC-SPLS 38.42 15.22 85.8 23.7 31.88 9.41 89.3 22.3
SI-SPLS 28.01 5.95 91.0 23.5 29.40 6.94 85.8 35.2
MI-SPLS 28.26 6.04 94.3 17.3 29.71 7.56 89.7 25.3
Full-ENet 27.14 5.39 78.5 65.8 26.94 4.99 80.0 66.7
CC-ENet 48.79 26.79 36.8 83.0 43.19 21.26 42.7 83.3
SI-ENet 27.33 5.61 76.8 65.7 28.54 6.64 71.3 65.3
MI-ENet 27.07 5.35 78.3 63.7 27.76 5.80 74.8 66.2
SI-WENet 27.20 5.50 77.7 63.8 28.03 6.07 74.8 64.2
MI-WENet 27.40 5.65 77.3 62.8 27.53 5.56 76.8 64.2
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Table 2.2: Simulation results for missing at random (MAR) scenarios with d-
ifferent missing patterns (independent and monotone) and different correlation
structures (compound symmetry with low correlation, compound symmetry with
medium correlation and first-order autoregressive (AR(1))) for p = 12 and n = 50.
Independent MAR Monotone MAR
PMSE MSE SENS SPEC PMSE MSE SENS SPEC
Low correlation: corr(Xi,j, Xi,j′) = 0.1
Full-SPLS 14.45 3.33 94.8 75.7 14.66 3.54 95.3 70.5
CC-SPLS 27.27 12.69 78.7 59.2 33.38 14.95 72.5 56.3
SI-SPLS 18.03 6.61 89.3 68.0 19.66 8.19 84.0 66.0
MI-SPLS 16.52 4.93 98.0 38.7 17.18 5.72 95.0 44.3
Full-ENet 13.83 2.71 96.8 78.8 13.93 2.88 97.2 75.2
CC-ENet 26.83 12.82 64.5 92.0 31.14 15.20 58.8 91.5
SI-ENet 16.90 5.73 90.7 77.2 18.25 7.07 85.2 72.8
MI-ENet 16.38 5.07 92.8 74.7 16.88 5.70 90.0 75.5
SI-WENet 16.57 5.35 91.3 78.3 17.20 5.96 88.7 73.5
MI-WENet 15.96 4.74 93.5 76.5 16.41 5.23 89.8 73.7
Medium correlation: corr(Xi,j, Xi,j′) = 0.5
Full-SPLS 32.28 7.24 90.5 34.5 32.77 7.67 89.0 38.0
CC-SPLS 40.92 16.02 81.3 40.2 49.39 19.42 79.8 38.2
SI-SPLS 35.15 9.57 80.7 45.0 35.49 9.47 81.3 41.5
MI-SPLS 34.69 8.83 91.5 30.8 34.88 8.69 90.7 34.3
Full-ENet 31.27 6.27 83.3 72.8 30.76 6.01 84.2 73.2
CC-ENet 53.89 27.42 47.5 91.3 58.18 28.58 43.8 88.8
SI-ENet 33.21 8.31 77.3 70.5 33.31 8.17 76.2 69.3
MI-ENet 32.72 7.79 78.2 69.0 32.22 7.20 77.5 68.2
SI-WENet 33.47 8.57 76.8 71.3 33.00 8.06 75.8 71.7
MI-WENet 32.63 7.66 78.8 69.0 31.94 6.99 78.2 67.8
AR(1) correlation: corr(Xi,j, Xi,j′) = 0.8|j−j
′|
Full-SPLS 27.36 5.66 89.7 30.2 27.45 5.82 87.5 31.0
CC-SPLS 33.11 11.68 81.0 36.3 43.08 15.44 75.8 35.8
SI-SPLS 30.46 8.28 81.3 40.3 30.33 7.31 81.3 42.0
MI-SPLS 30.96 8.46 91.0 23.5 30.02 7.15 89.2 27.3
Full-ENet 26.91 5.19 78.5 66.8 26.59 5.04 78.5 70.5
CC-ENet 45.50 22.77 41.8 84.5 53.26 28.26 38.0 87.2
SI-ENet 30.21 8.30 67.8 70.5 28.28 6.68 69.3 72.2
MI-ENet 28.76 6.93 72.8 69.2 27.76 6.05 72.7 70.5
SI-WENet 28.81 7.01 70.3 67.5 27.95 6.37 69.0 72.0
MI-WENet 27.97 6.34 73.8 68.8 27.22 5.63 73.5 69.8
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mance in terms of smallest PMSE and MSE, and relatively high sensitivity and
specificity compared to all the ENet based imputation methods. However, we
observe a higher sensitivity with a significant loss of specificity in the SPLS based
imputation methods. Although we see the reduced sensitivity in MI-ENet impu-
tations for highly correlated data compared to many SPLS based imputations. The
lower sensitivity is not as severe compared to the loss of specificity in the SPLS
based imputations. The second column in Table 2.3 illustrates the performance of
different methods when the number of predictor variables increases from 24 to 60
with fixed sample size n at 50, from which we conclude that: (1) as p increases
(say p = 24, 48, 60), the PMSE and MSE for each method increase apparently; (2)
as p gets larger, the sensitivity decreases, and the specificity slightly decreases as
well for SPLS methods, while increase slightly for ENet methods; (3) in general,
the performance of MI-WENet is as good as the Full-ENet.
To examine whether a large number of simulation runs impacts the simulation
results, I carried out the simulations of the same scenarios as presented in Tables
3 but with 500 simulation runs. The results are presented in Table 2.4, from which
we can see the results with 500 runs are very similar to those with 100 simulation
runs (See Table 2.3).
Based on all simulation results, I conclude that the MI-WENet method obtains
more or less the lowest PMSE and MSE among all the imputation based methods.
The sensitivity and specificity of the MI-ENet method is better than all other
ENet based imputation methods. In some cases although it looses in terms of
sensitivity to some of the SPLS based imputation methods its loss in sensitivity
is not as severe as the loss of specificity in some of the SPLS based imputations.
Moreover, in most of our simulation scenarios, the PMSE, MSE, sensitivity and
specificity from MI-WENet are closest to those from ENet on fully observed data.
MI-WENet is therefore recommended for variable selection and prediction when
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Table 2.3: Simulation results for scenarios with different combinations of p and
n under monotone MAR and AR(1) correlation structure specifications based on
100 simulation runs.
PMSE MSE SENS SPEC PMSE MSE SENS SPEC
p = 12, n = 50 p = 24, n = 50
Full-SPLS 27.45 5.82 87.5 31.0 24.25 7.33 87.7 54.4
CC-SPLS 43.08 15.44 75.8 35.8 43.97 18.29 78.2 47.2
SI-SPLS 30.33 7.31 81.3 42.0 26.40 9.15 80.8 59.6
MI-SPLS 30.02 7.15 89.2 27.3 29.33 11.66 91.0 26.8
Full-ENet 26.59 5.04 78.5 70.5 22.81 5.89 82.5 82.7
CC-ENet 53.26 28.26 38.0 87.2 47.90 27.29 41.7 93.4
SI-ENet 28.28 6.68 69.3 72.2 24.17 7.24 75.0 83.2
MI-ENet 27.76 6.05 72.7 70.5 23.15 6.19 78.3 82.7
SI-WENet 27.95 6.37 69.0 72.0 23.78 6.85 78.3 82.7
MI-WENet 27.22 5.63 73.5 69.8 23.03 6.08 79.3 84.3
p = 12, n = 100 p = 48, n = 50
Full-SPLS 24.89 2.96 90.7 35.0 64.14 26.81 84.6 38.7
CC-SPLS 40.66 13.77 80.0 40.5 125.58 63.08 68.1 39.9
SI-SPLS 27.12 4.67 82.8 47.7 71.94 35.72 75.8 44.2
MI-SPLS 26.46 4.13 91.8 33.3 122.30 81.38 87.8 24.7
Full-ENet 24.35 2.44 89.5 68.2 62.51 26.75 55.6 87.1
CC-ENet 46.01 19.01 53.0 86.8 139.63 95.08 16.2 95.6
SI-ENet 26.13 4.06 79.5 70.7 79.43 43.50 45.1 86.8
MI-ENET 25.98 3.85 81.2 70.0 72.33 36.19 52.2 83.0
SI-WENet 25.61 3.71 80.5 69.8 77.47 41.56 47.2 86.9
MI-WENet 25.34 3.41 83.0 72.2 69.98 34.01 53.5 84.4
p = 12, n = 200 p = 60, n = 50
Full-SPLS 23.26 1.53 97.2 35.3 86.32 39.61 85.1 32.0
CC-SPLS 33.61 9.76 87.2 34.8 172.15 89.69 65.5 42.1
SI-SPLS 24.92 3.07 90.0 54.5 95.03 48.63 79.5 38.5
MI-SPLS 24.69 2.83 95.8 39.2 276.42 218.87 91.8 11.6
Full-ENet 22.95 1.20 97.3 71.2 91.66 46.41 48.9 86.7
CC-ENet 38.12 11.94 68.0 83.8 183.00 126.53 14.5 95.4
SI-ENet 24.63 2.76 89.5 75.2 105.60 60.05 40.9 87.2
MI-ENet 24.36 2.48 92.2 71.2 97.83 52.21 46.9 86.8
SI-WENet 23.84 2.06 92.0 72.5 103.51 58.41 41.7 87.9
MI-WENet 23.72 1.97 93.0 69.7 94.69 49.27 47.9 86.6
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Table 2.4: Simulation results for scenarios with different combinations of p and
n under monotone MAR and AR(1) correlation structure specifications based on
500 simulation runs.
PMSE MSE SENS SPEC PMSE MSE SENS SPEC
p = 12, n = 50 p = 24, n = 50
Full-SPLS 27.90 6.11 88.1 30.4 24.36 7.16 88.0 52.3
CC-SPLS 44.22 16.62 77.0 38.0 44.36 18.91 77.0 47.1
SI-SPLS 30.82 8.16 79.2 45.6 26.67 8.97 81.2 60.8
MI-SPLS 30.67 8.10 87.4 29.8 29.30 11.45 92.5 27.5
Full-ENet 27.11 5.34 78.2 68.6 22.95 5.93 80.9 82.7
CC-ENet 53.80 28.20 38.1 85.6 47.73 27.26 40.1 93.0
SI-ENet 29.49 7.63 68.4 73.5 24.56 7.53 74.2 82.2
MI-ENet 28.62 6.70 70.7 73.7 23.36 6.34 77.9 82.8
SI-WENet 28.85 7.04 69.8 72.5 24.09 7.03 76.6 82.3
MI-WENet 27.97 6.16 73.0 72.4 23.25 6.20 78.1 83.1
p = 12, n = 100 p = 48, n = 50
Full-SPLS 24.80 3.16 92.8 32.7 64.41 27.52 84.9 40.0
CC-SPLS 37.82 12.56 82.2 38.2 117.09 56.28 74.1 36.0
SI-SPLS 26.90 4.79 83.8 48.6 75.06 38.56 75.6 45.2
MI-SPLS 26.34 4.35 91.8 33.0 116.28 76.58 85.4 25.8
Full-ENet 24.18 2.52 90.3 67.2 64.41 28.48 57.2 85.2
CC-ENet 44.37 18.25 54.4 85.2 137.51 93.63 17.0 95.4
SI-ENet 26.15 4.38 79.4 70.2 78.09 42.30 45.5 84.7
MI-ENET 25.63 3.79 82.7 70.5 72.12 36.19 52.5 83.5
SI-WENet 25.21 3.53 83.3 68.9 76.92 40.97 47.1 85.1
MI-WENet 24.88 3.20 85.6 69.1 69.80 33.94 54.7 83.6
p = 12, n = 200 p = 60, n = 50
Full-SPLS 23.27 1.57 96.2 36.7 84.43 37.53 83.6 34.8
CC-SPLS 33.71 9.82 87.8 33.9 164.11 82.84 69.4 39.1
SI-SPLS 24.86 2.98 88.7 55.2 96.66 49.80 76.1 40.4
MI-SPLS 24.55 2.70 96.0 36.9 285.05 225.15 91.0 15.6
Full-ENet 23.02 1.27 97.2 70.0 88.60 43.01 50.6 86.3
CC-ENet 36.95 10.69 70.1 84.8 183.30 128.18 13.8 95.7
SI-ENet 24.49 2.64 88.2 71.1 104.67 59.05 40.6 87.2
MI-ENet 24.26 2.37 92.6 70.4 99.70 54.00 45.3 86.1
SI-WENet 23.76 2.00 91.8 71.5 103.13 57.48 41.4 87.2
MI-WENet 23.60 1.85 94.2 70.2 97.24 51.57 46.3 86.4
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missing data exist.
In the following section, I applied the MI-WENet method to examine which
variables were associated with the median effective dose and maximum effect
in an ex-vivo phenylephrine-induced extension and acetylcholine-induced relax-
ation experiment.
2.4 Case Study
The high-fat diet and normal chow fed mouse model has been used to ex-
amine the mechanisms by which high-fat diet impacts cardiovascular function.
Early on, high fat diet feeding induces endothelium inflammation, insulin resis-
tance and endothelium dysfunction, which precedes the onset of diabetes (Kim
et al., 2008). Thus, endothelium dysfunction, characterized by decreased nitric
oxide (NO) production or bioavailability, is used as a robust and early indicator
of cardiovascular injury (Rizzo et al., 2010). In the mouse model, mice were ran-
domly assigned to high-fat diet and normal chow groups. The mice were fed
for 12 weeks. Their body weight (BW), organ weight, blood variables and an
array of plasma compositions and the ex-vivo endothelial functional outcomes
were measured. Organ weights included heart, liver, kidney and spleen weight.
The blood variables included percentage of red blood counts (%RBC, i.e., hema-
tocrit) and percentage of white blood counts (%buffy). The plasma parameters
included the counts of cholesterol , triglyceride, albumin, total protein (TP), high
density lipoprotein (HDL), low density lipoprotein (LDL), alanine aminotrans-
ferase, aspartate aminotransferase, creatine kinase, alkaline phosphatase, creati-
nine, hemoglobin A1c (HbA1c), insulin, and nitrogen oxide species (NOx, i.e., the
sum of nitrite (NO2) and nitrate (NO3)), the ratio of HDL to LDL, and the per-
centage of albumin to total protein (Alb/TP). Isolated aorta were contracted with
phenylephrine and relaxed with acetylcholine as previously published (Conklin
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et al., 2009). Percentage relaxation based on maximal contraction was calculated
for each aorta. The percentage of maximal relaxation is called the Emax, and
the acetylcholine concentration needed to achieve 50% relaxation is called the ef-
fective concentration producing 50% response, i.e., EC50. Emax and EC50 are
two important parameters used to quantify endothelial function. In this section,
we examined whether the two measurements of endothelial function, Emax and
EC50, were related to any of the blood variables, plasma parameters, organ and
body weights of the mice.
The final data set included 22 mice and 28 measured predictor variables. Some
values in the predictor variables were missing due to inadequate volume of plas-
ma. In total, 8 mice had missing observations. In order to include the 8 mice in
the analysis, we applied the MI-WENet method to examine what variables were
closely associated with the measurements of endothelial function. To apply the
MI-WENet method, we imputed 5 realizations for each missing value, and stacked
the five imputed data sets into one large data set. Each variable was scaled to have
unit variance before multiple imputation, and there was no additional standard-
ization carried out after imputation. Thus, the subjects without missing values
remained the same in the stacked data set. The log-transformation for EC50 was
applied to ensure the normality of residuals. I applied the MI-WENet method
to the stacked multiple imputed data set to obtain the coefficient estimates and
select the important predictor variables. In addition, I applied leave-one-out cross
validated samples to construct 95% confidence intervals (95% CIs) for the estimat-
ed coefficients. The predictor variables whose 95% CIs did not contain zero were
selected as the important variables for predicting the measurements of endothe-
lial function. The estimates for the selected important predictors and their 95%
CIs are shown in Table 2.5.
The selected important predictors for Emax were NOx and the ratio of kidney
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Table 2.5: The estimated coefficients and their 95% CIs based on leave-one-out
samples for Emax and EC50 using the MI-based weighted ENet method.
Covariate Estimate 95% CI-low X95% CI-up
Emax
NOx 0.1894 0.0792 0.2997
kidney/BW 0.2664 0.0128 0.5200
EC50
NOx -1.0803 -1.6983 -0.4623
kidney -1.2246 -1.9112 -0.5379
kidney/BW -1.7004 -2.6188 -0.7821
spleen -1.5503 -2.3522 -0.7484
spleen/BW -1.9629 -2.5398 -1.3860
heart/BW -0.9037 -1.5152 -0.2923
TP -1.0097 -1.4712 -0.5481
Alb/TP -0.9950 -1.4623 -0.5276
HDL -1.1533 -1.6846 -0.6220
LDL -1.0116 -1.4736 -0.5497
to body weight. The selected important predictors for the log-transformed EC50
were NOx, kidney weight, the ratio of kidney to body weight, spleen weight, the
ratio of spleen to body weight, the ratio of heart to body weight, TP, Alb/TP,
HDL and LDL. Endothelium dysfunction is commonly associated with decreased
nitric oxide production and/or bioavailability (Hadi et al., 2005; Davignon and
Ganz, 2004; Versari et al., 2009). The current results show that the decreased NOx
is associated with decreased Emax and increased EC50, which is consistent with
previous findings. The other findings, such as association between endothelium
dysfunction and kidney/BW, are also interesting and may be investigated further.
The selected important predictor NOx for Emax and EC50 demonstrates the se-
lection precision of our proposed model, and thus, re-emphasizes the importance
of using these endpoints to highlight the fundamental role of the endothelium in
diet-induced cardiovascular injury.
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2.5 Discussion and Conclusions
Missing data is common in animal experiments and clinical studies. In this
project I concentrated on the cases with missing covariate values. One of the fre-
quently used methods in practice is the complete case analysis which ignores the
covariates with missing observations. This method is easy to carry out, while it is
inefficient and sometimes incorrect because the missing observations may not be a
random subset of the whole sample. In this chapter, I proposed a multiple impu-
tation based weighted elastic net method (MI-WEnet) for variable selection and
prediction. The simulation studies demonstrated that the proposed MI-WENet
method was able to identify important predictor variables with similar precisions
as the SPLS and elastic net methods would have achieved if the data were com-
pletely observed. Sensitivity and specificity obtained by the MI-WENet method
were close to the results from the ENet method based on the full data in all the
tested simulation scenarios. In addition, the MI-WENet method had the lowest
MSE and PMSE among almost all methods we have evaluated. The simulations
also showed that the use of SPLS and ENet on complete cases only resulted in
models with poor sensitivity and much larger PMSE and MSE than MI-WENet,
especially when proportion of missing data is high and the missing patterns are
MAR. This again indicates that the use of MI-WENet is especially recommended
when proportion of missing values of the covariates is moderate to high.
MI-WENet maintained a balanced sensitivity and specificity in all the sim-
ulation scenarios and all the imputation schemes. The MI-WENet is also easy
to implement. By applying the cyclical coordinate descent algorithm (Friedman
et al., 2010), the coefficients of MI-WENet can be easily estimated by iterative-
ly minimizing the weighted penalized least squares. The computational cost is
mainly affected by the number of predictor variables not the sample size. R code
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for implementing the MI-WENet method can be obtained upon request. At last,
it should be pointed out that the weights we proposed account for the available
information in an observation; how to account for the available information more
accurately is challenging and is beyond the scope of the current work.
32
TOPIC II: MONOTONIC SINGLE-INDEX MODELS WITH APPLICATION TO
ASSESSING DRUG INTERACTION
3.1 Introduction
Single-index models have been extensively studied in the statistical literatures
(Stoker, 1986; Härdle and Stoker, 1989; Ichimura, 1993; Yu and Ruppert, 2002).
A single-index model could be considered as an extension of a general linear
model. Recall that a general linear model is defined as Y = Xα + ε, where X is a
vector of covariates X = (X0, X1, ..., Xp), and α = (α0, α1, ..., αp)T is an unknown
parameter vector. A single-index model generalizes the general linear regression
by replacing Xα with a nonparametric function of Xα, say f (Xα), where f is an
unknown univariate link function, and α remains the same. In the literature, f is
usually estimated by using kernel spline (Ichimura, 1993; Härdle and Stoker, 1989;
Xia and Härdle, 2006), or using penalized spline (Yu and Ruppert, 2002). Both α
and f are unknown and need to be estimated. For identification, one may either




1 + ... + α
2
p = 1
and α0 > 0. The asymptotic properties for α have been established (Stoker, 1986;
Härdle and Stoker, 1989; Ichimura, 1993; Yu and Ruppert, 2002). A single-index
model reduces the dimensionality from multivariate predictors to a univariate
index z (say z = Xα), while it still captures important features in high-dimensional
data (Yu and Ruppert, 2002). Any interactions between the covariates can also
be included in the single index z. Single-index model has wide application in
econometrics (Stoker, 1986; Härdle and Stoker, 1989; Ichimura, 1993) as well as in
biometrics (Yu and Ruppert, 2002).
Although single-index models have been well studied, the function f in the
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single-index models is not necessary monotonic. In certain applications, it is de-
sirable to have the function f monotonic. For example, in the dose-response stud-
ies, the dose response relationship is often assumed to be monotonic (Kong and
Eubank, 2006; Ramsay and Barahamowicz, 1989; Ramsay, 1998). In the combina-
tion drug studies, the dose response relationship is often described by a response
surface model (Greco et al., 1995). It is desirable that the response surface mod-
el is reduced to a dose-response curve when only one drug is applied. Without
loss of generality, let denote the response at the combination dose (d1, d2) is y. A
relative potency, say ρ, is often used to describe how effective drug 2 is relative
to drug 1, that is the effect of drug 2 at dose level d2 when applied alone, is the
same as that of drug 1 at dose level ρd2. If we assume the dose-response curve
for drug 1 is y = f (d1), then the dose-response curve for drug 2 is f (ρd2). In
case that the two drugs do not have any interaction, i.e. the combination is addi-
tive, the effect of the combination dose (d1, d2) can be described by f (d1 + ρd2).
If the effect at (d1, d2) is more (or less) than the effect of drug 1 at dose level
d1 + ρd2, we say the combination dose (d1, d2) is synergetic (or antagonistic) (Lee
et al., 2007; Berenbaum, 1989). Plummer and Short (1990) used a model of the for-
m f (d1 + ρd2 + k
√
d1d2) identify and quantify departures from additivity, where
k > 0 indicates synergy of the combination dose at (d1, d2), and k < 0 indicates
antagonism of the combination dose at (d1, d2). Kong and Lee (2006) extended
the model of Plummer and Short (1990) by replacing k with a quadratic function
of (d1, d2) so that the model has the flexibility to capture different patterns of
drug interaction, i.e. some combination dose may be synergistic and some may
be antagonistic (Savelev et al., 2003). These models can be rewritten as the form
of f (xTα). For example, one may set x = (d1, d2,
√
d1d2) and α = (1, ρ, κ) for
Plummer and Short (1990)’s model.
Note that in the approaches by Plummer and Short (1990) and the extension by
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Kong and Lee (2006), the function is assumed to be monotonic parametric model.
The estimates of α can be biased when the parametric function f is misspecified.
To avoid the problem caused by the misspecification of the function f , we do
not assume any specific function form for f . Instead, we only assume that f
is monotonic and has continuous first and second derivatives. The function f is
estimated by using penalized splines with I-splines as its basis functions (Ramsay,
1998). The monotonicity of the function f is achieved by adding constraints to
the coefficients of I-splines basis functions (Kong and Eubank, 2006; Ramsay and
Barahamowicz, 1989; Ramsay, 1998). The presentation of this topic is organized
as follows. In Section 3.2, I propose the single-index model for assessing drug
interactions, and develop algorithm for estimating the monotonic function f and
the parameter α in the single-index model. Simulation studies are carried out
in Section 3.3 to examine the performance of the proposed model in term of
accuracy in estimating f and α. In Section 3.4, I apply the proposed monotonic
single-index method to examine the drug interaction of two drugs in a case study
given by Harbron (2010). The last section is devoted to a discussion.
3.2 Monotonic Single-index Model
3.2.1 Monotonic Single-index Model
Let yi denote the response observed at the combination dose (d1i, d2i) (i =
1, ..., n). In case that drug 1 is applied alone, d2i is set to zero. Similarly, d1i is set to
zero if drug 2 is applied alone. In the literature, the dose-response curve is usually
described by a parametric function, which may not be specified correctly. In the
project, we develop dose-response surface model under the minimal assumption
that the dose-response curve is monotonic. Similar to Kong and Lee (2008), a
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quadratic function of (d1, d2) of the form




d2 + κ3d1 + κ4d2 + κ5
√
d1d2, (3.1)
is used to capture different patterns of drug interaction. I propose the following
response surface model to assess different patterns of drug interactions:
y = f
(





where f is monotonic function and is estimated by cubic splines, and ε is a ran-
dom error with mean zero and variance σ2.
Denote
αT = (1, ρ, κ0, κ1, κ2, κ3, κ4, κ5)





















+ εi, i = 1, ..., n (3.4)
subject to α0 = 1 and f is monotonic.
Let us denote zi = xTi α (i = 1, ..., n), zi is often called single index for x
T
i =
(xi0, ..., xip). Let us also denote a knot sequence τ = {τj}Kj=1, where min{zi, i =
1, ..., n} = L = τ1 < τ2 < ... < τK = U = max{zi, i = 1, ..., n}. The function
f is defined on the domain [L, U] over which f is approximated by a piecewise
polynomial function in each interval [τl, τl+1], and the two polynomials in the two
adjacent intervals, say [τl−1, τl] and [τl, τl+1], are required to join smoothly. The
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most commonly used spline is the cubic spline in which each polynomial is a cu-
bic, and the piece-wise polynomials are joined at each knot with continuous first
and second derivatives so that the curve changes smoothly. There are different
basis functions for cubic splines, such as B-splines, M-spines, and I-splines (Ram-
say, 1998). I found I-splines are convenient for constructing monotonic curves
(Ramsay, 1998).
In general, the I-spline basis function of degree k is determined by k + 1 knots,





with z ∈ [L, U] and j = 1, 2, ..., K − k. Here the M-splines can be iteratively ob-








(k− 1)(τj+k − τj)
, (3.6)




τj+1−τj , τj ≤ z < τj+1;
0, otherwise.
(3.7)
Because the M-spline basis Mkj (z) is a piecewise nonnegative polynomial of de-
gree k− 1, the corresponding I-spline basis function Ikj (z) is therefore a piecewise
monotone polynomial of degree k (Ramsay, 1988). The I-spine function Ikj (z) can
also be put in a more convenient form
Ikj (z) =






m (z), l − k + 1 ≤ j ≤ l
1, j < l − k + 1,
.
37
for any z ∈ [τl, τl+1]. In the rest of this presentation, I set k=3. The monotonic






β j I3j (z), (3.8)
subject to β j ≥ 0 for j = 1, ..., K− 3. The parameters βT = (β1, ..., βK−3) in equation























The second term in (3.9),
∫ U
L f
′′(u)2du, can be written in the form of βTDβ, where









which is specified in Appendix A. Thus, given the indices zi = xTi α (i = 1, ...., n)
and knots sequence, one can obtain the estimate of f from minimizing the PRSS
in equation (3.9).
To obtain the estimate for α, for fixed function f , one may minimize the fol-










Consider the first order Taylor expansion for f (xTi α) at α
(0):
f (xTi α) ≈ f (xTi α(0)) + f ′(xTi α(0))xTi (α− α(0))
= f (xTi α
(0))− f ′(xTi α(0))xTi α(0) + f ′(xTi α(0))xTi α,






y∗i − x∗Ti α
}2
, (3.13)
where x∗i = f
′(xTi α
(0))xi and y∗i = yi − f (xTi α(0)) + f ′(xTi α(0))xTi α(0). By replacing
α(0) by the current available α and using the first order Taylor expansion, one can
minimize the RSSE for α. It should be noticed that the estimates for α and f are
obtained iteratively. That is, given α, one estimates f ; and given f , one estimates
α. The iteration continues until the estimates of α from two adjacent estimations
of f are close enough.
3.2.2 Algorithm for Estimating f and α
The algorithm for estimating α and f can be described as the follows:
Step 1. Set a grid of 100 values for λ (λ > 0) by equally spacing λ in log-scale.
For each fixed λ (given α) obtain the monotonic link function by minimizing the
PRSS in (3.9). Set the optional link function as the one which has the minimum
generalized cross validation (GCV) score, which has the following form
GCV(λ) =
n−1 ∑ni=1{yi −∑K−3j=1 β̂ j Ij(xTi α̂)}2
{1− n−1tr(Sλ)}2
,
where tr(Sλ) = tr{I(IT I + nλD)−1 IT}, and I = (I1, ..., IK−3) is the matrix of I-
spline basis on the estimated single-index ẑi = xTi α̂, for i = 1, ..., n.
Step 2: Given the estimate of f , α is obtained by minimizing the RSSE in (3.13).
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Step 3: Repeat step 1 and step 2 until the estimates of α from two repeats are
converged within a small tolerance error.
Remark: In nonparametric regression, the trace of smoothing matrix Sλ is often
called the degrees of freedom of the fit (Hastie and Tibshirani, 1990), i.e., d f f it =
tr(Sλ). It has the rough interpretation as the equivalent number of parameters
as defined in linear regression. The residual degrees of freedom is defined as
d fres = n− 2tr(Sλ) + tr(SλSTλ). Consequently, the error variance σ2 in model (3.4)
can be estimated by σ̂2 = RSSE/d fres, where RSSE = ∑ni=1{yi − f̂ (xTi α̂)}2.
3.2.3 Variance Estimate for α̂ and Assessing Drug Interaction
The asymptotic properties for α̂ in single-index model have been studied by
Hardle et al (2000) and Xia et al. (2006) using kernal estimation for f and by Yu
and Ruppert (2002) using penalized splines. Under the assumption that f̂ is an
unbiased estimate for f , α̂ has the following asymptotic property:
√
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∂ f (xTi α)
∂α
(yi − f (zi))2








( f ′(zi))2(yi − f (zi))2xixTi . (3.16)






where V̂ and Σ̂ are obtained by replacing every quantity in (3.15) and (3.16) by
their final estimates, respectively. Note that the model is developed to assess drug
interaction. It is important to estimate the quantity of the function g(d1, d2; α) in
(3.1) and estimate its variation so that the inference for drug interaction can be
made with statistic rigor. Indeed, the function g(d1, d2; α) can be written as a











estimate α̂ and its variance become available, the variance for g(d1, d2; α) can be
obtained as uTVar(α̂)u. Thus the 95% confidence interval (CI) for g(d1, d2; α̂) can
be constructed as g(d1, d2; α̂)± zα/2
√
uTVar(α̂)u. An alternative approach for the
variances of g(d1, d2; α̂) can be obtained by using bootstrap method that is shown
in Appendix B.
3.3 Simulation
Extended simulation studies were performed to examine the finite-sample
properties of the estimates of the proposed model, with a set of parameters
α = (1, 1, 0, 0, 0, 0.5,−0.5, 0) was considered. The corresponding response surface













where ε ∼ N(0, σ2). I generated 100 random samples with σ = 0.01, and d1 and d2
taking values among (0, 0.1, 0.5, 1, 2, 4). The replicates for each sample was set as
3. Then the total sample size in each simulation run was 3× 6× 6 = 108. I fitted
each random sample to the full model as specified in Equations (3.1) and (3.2),
and obtained the estimated parameters and their corresponding standard errors
(SE). The averages of the estimated parameters (Est.), averaged SE (SE.Ave), and
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the standard error of the estimates from the 100 estimates of α (SE.Emp) were
reported in Table 3.1.
Table 3.1: Simulation results from fitting the full model based on the 100 simulat-
ed data.
g(d1, d2; α) = 0.5d1 − 0.5d2
Parameters True value Est. SE.Ave SE.Emp
α0 1.0 1.000 0.001 0.000
α1 1.0 0.999 0.004 0.004
α2 0.0 0.022 0.031 0.034
α3 0.0 -0.012 0.038 0.057
α4 0.0 -0.026 0.028 0.044
α5 0.5 0.489 0.013 0.048
α6 -0.5 -0.496 0.010 0.016
α7 0.0 0.018 0.012 0.029
Figure 3.1 showed the contour plot of the underlying polynomial function
g(d1, d2) in panel A. We can see that some combination doses are synergistic (i.e.,
g(d1, d2) > 0), and some combinations doses are antagonistic (i.e., g(d1, d2) < 0).
The underlying polynomial function g(d1, d2) and the fitted polynomial function
for the 100 simulations are plotted in panels B1-B5 of Figure 3.1, where the x-axis
is the dose level for drug 1 under each fixed drug 2 dose level. The underlying
function g(d1, d2) and the 95% limit bounds based on the 100 simulation data are
shown in panels C3-C5 of Figure 3.1.
Based on the simulation results shown in Table 3.1 and Figure 3.1, I conclude
that (1) the estimates of the parameters in the single-index model were unbiased
(Table 3.1); (2) the functions g(d1, d2) ware estimated correctly (panels B1-B5 and
C3-C5 of Figure 3.1); (3) the empirical standard errors (Table 3.1 under column
"SE.Emp") were close to the formula based SE (Table 3.1 under column "SE.Ave"),
indicating the variance estimates were reasonable.
42
Figure 3.1: The results from simulation studies. Panel A shows the contour plot
of the underlying polynomial function g(d1, d2). Each of the panels B1-B5 shows
the underlying curve (solid lines) and the fitted curves (dotted lines) based on
100 simulation runs. Panels of C3-C5 present the underlying curve (solid lines),
the mean of fitted curve (dotted line), and the 95% point-wise confidence bounds
(dashed lines).



















A: Contour Plot of g(d1, d2)








B1: Drug 2 at 0













B2: Drug 2 at 0.1













B3: Drug 2 at 1













B4: Drug 2 at 2













B5: Drug 2 at 4



























C4: Drug 2 at 2













C5: Drug 2 at 4







In this section, I studied a real case data resulting from an in vitro combination
experiment (Harbron, 2010). In the data set, there were two compounds A and B,
both dosed in monotherapy along a 9 dose levels with 3 replicates in each dose
level. The two compounds were combined in a factorial design manner for all
of the 6 lower doses (Table 3.2). All design points were tested in triplicate. The
Table 3.2: Experimental results (per cent inhibition) from a combination study.
Dose of compound B
Dose of compound A 0 0.037 0.11 0.33 1 3 9 27 81 243
0
3.1 1.0 1.0 8.5 13.3 23.7 53.1 78.9 93.5
1.5 1.0 8.8 1.0 14.7 30.2 59.0 82.9 98.8
1.0 1.0 5.9 4.5 18.1 42.5 62.0 81.5 96.2
0.037
1.0 1.0 1.0 1.0 8.4 21.8 38.5
5.8 2.0 1.0 2.9 10.0 4.7 34.9
1.0 1.0 1.0 4.2 7.6 9.5 35.2
0.11
1.0 1.0 2.6 1.0 5.4 22.2 32.8
1.0 1.0 1.0 2.5 9.8 22.5 34.8
1.0 1.0 9.2 2.0 8.9 15.6 30.4
0.33
1.0 1.0 1.0 4.7 8.5 22.5 37.9
4.2 6.2 4.9 6.3 12.3 19.8 41.7
13.3 6.1 9.5 5.6 7.2 15.9 34.3
1
1.9 16.0 3.4 21.2 22.9 34.0 52.9
4.2 6.0 6.6 19.6 23.4 37.7 46.4
5.7 15.8 15.5 14.7 26.4 42.1 53.9
3
20.6 41.1 49.4 43.0 50.5 55.8 66.8
31.7 42.1 50.4 48.3 40.0 56.6 59.2
23.9 43.1 51.3 46.1 52.5 61.8 64.2
9
56.2 69.2 66.8 76.8 84.7 75.6 77.5
58.5 82.1 83.5 83.4 79.3 68.6 77.6













percentage of growth inhibition of a cell culture was measured as the endpoint.
It is calculated from an optical density, corrected for background and normalized
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Table 3.3: The estimates of α and their standard error estimates based on model
formula and bootstrap method.
Direct estimates Bootstrap estimates
Par. Est. SE CI.low CI.up SE CI.low CI.up
α0 1.00 0.00 1.00 1.00 0.00 1.00 1.00
α1 0.34 0.14 0.07 0.62 0.03 0.29 0.40
α2 -0.20 0.66 -1.49 1.08 0.61 -1.25 1.16
α3 1.62 0.54 0.57 2.68 0.51 0.61 2.61
α4 0.26 0.86 -1.43 1.95 0.48 -0.76 1.13
α5 -0.03 0.14 -0.30 0.24 0.15 -0.36 0.24
α6 -0.06 0.30 -0.64 0.52 0.10 -0.25 0.16
α7 -0.41 0.17 -0.74 -0.07 0.13 -0.65 -0.14
against an average no treatment response (Harbron, 2010). I set the grid of penalty
parameter as λ ∈ [10−10, 1010] by equally spacing log(λ) on [−10, 10].
The plot of GCV versus λ at final step is shown in Figure 3.2. The optimal
λ was λ = 0.012 after 19 iterations. The estimates of α and their 95% confidence
intervals based on model-based variances and bootstrap variances were presented
in Table 3.3, and both gave similar results.
Figure 3.2: The plots of penalty parameter λ vs GCV. The top plot is for
log(λ) ∈ [−10, 10], and the bottom plot is for log(λ) ∈ [−10, 0]. The minimum
GCV corresponds to λ = 0.012.





















Figure 3.3 showed the fitted f̂ (xT α̂) versus the indices xT α̂ as the solid lines
and the observed responses as circles (panel A1), the fitted function f̂ when only
drug A was applied (panel A2), when only drug B was applied (panel A3), and
when drug A and drug B were combined with equal amount (panel A4). To
facilitate viewing, Figure 3.3 is shown on a logged scale, though the analysis was
performed on the unlogged dose scale. From Figure 3.3, it is clear that the model
fitted the data very well for all data (panel A1), marginal dose-response (panels
A2 and A3), and a typical combinations (panel A4).
Figure 3.3: Fitted response versus the estimated single-index (panel A1), fitted
responses versus dose of drug A when drug A was applied alone (panel A2),
dose of drug B when drug B was applied alone (panel A3), and dose of drug A
when drug A was combined with drug B in equal amount (panel A4).
















A2: Dose−response for drug A















A3: Dose−response for drug B





























In Figure 3.4, panel A showed the contour plot of the fitted response sur-
face, and panel B showed the contour plot of the polynomial function g(d1, d2; κ),
where the dotted curve is the intercept of lower 95% confidence surface with
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Figure 3.4: Contour plot of response surface of the combination of compounds A
and B (panel A), and contour plot of polynomial function g(d1, d2; κ̂) (panel B).


















A: Contour Plot of Fitted Response Surface


















B: Contour Plot of the Polynomial Function g()
ĝ(d1, d2; κ) = 0. From panel B of Figure 3.4, I concluded that the combination
doses for all but left side of the dashed lines were synergistic, the combination
dose with low level of drug A (left side of the dashed lines) were additive. The
results were consistent with the findings of Harbron (2010).
3.5 Discussion and Conclusions
Based on simulation and case study, I conclude that the proposed monotonic
single-index modeling approach worked effectively in assessing the interactions
of two drugs. By using I-spline basis, we can easily construct a monotonic link
function f in the single-index model to describe the dose-response relationship.
The estimates of both f and α are unbiased. The polynomial function g(d1, d2; κ)
is estimated accurately to capture different patterns of drug interaction. The ap-
proach can be extended to assess drug interaction of multiple drugs. The algo-
rithm was implemented in R and will be made public available to facilitate the
use of this method.
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According to (Ramsay, 1998), the primary distinction between smoothing s-
plines and regression splines is how to place the knots. The knots selection tech-
nique for classical smoothing splines is to select all unique values of z. The knots
for regression penalized splines are usually selected from a smaller set of candi-
dates. The more knots on the interested region of z, the more flexible the spline is.
This principle applies locally, such that if we need a lot of flexibility in a particular
region of z, we use more knots in this region, and we may use less knots in the
region if we don’t need much curvature. However, to decide how many knots
needed and where to position the knots is often challenging. Practically, user first
simply make knots equally spaced, while paying attention to the requirement of
having at least one observation in every subinterval. The optimal number of knots
K should be sufficiently large to fit the data, meanwhile K can not be so large that
computation time is excessive or the estimated curve f is over-fitted. Unfortunate-
ly, there is no standard rules to decide the number of K. Penalized splines tend
to select more knots but add penalty to make fitted curve more smooth. Ruppert
(2002) has made a detailed study of the choice for K for penalized splines. How-
ever, the algorithm developed by Ruppert (2002) may either stop prematurely or
there are multiple local minimums of GCV(λ) at the sequence of K. Therefore, the
selection of K seems challenging.
In this chapter, I applied a penalty approach that is similar to smoothing s-
plines but with a little fewer knots. In order to fit data to capture as enough
features as possible while to save computation burden, I proposed a new knots
selection approach. Use all the unique values of z as knot candidates, and include
min(z) and max(z) into the knot sequence first. By setting up a jump width w, say
w = 0.1, suppose zj is an element selected in the knot sequence, if zj+1 − zj > w,
we maintain zj+1 in the knot sequence; otherwise we drop zj+1 and examine
whether zj+2 − zj > w. A subset of indexes z is then formed as knots with the
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distance of any two knots being larger than w. By using this approach, we avoid
the dense knot values and include important z values in the knot sequence. The
simulation and case study showed this approach provided efficient way for knots
determination.
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TOPIC III: A STUDY FOR PREDICTING PATIENT SURVIVAL TIME WITH
HIGH THROUGHPUT MASS SPECTROMETRY DATA
4.1 Introduction
Genomic and proteomic technologies have become more and more important
in biomedical studies in a recent time. The use of mass spectrometry as a diag-
nostic tool and identification of proteomic biological markers has risen extensively
and demonstrated great advantage that led to the discovery of numerous protein-
s and protein profiles associated with various types of diseases (Stoeckli et al.,
2001; Adam et al., 2002; Aebersold and Mann, 2003; Rai and Chan, 2004; Datta
et al., 2008; Datta and Pihur, 2010). In this chapter, I aim to develop an effec-
tive model for predicting the survival time of cancer patients via penalized linear
regression modeling on log-transformed failure times by the proteomic features
as obtained from the matrix-assisted laser desorption/ionization Time-of-Flight
mass spectrometry (MALDI-TOF-MS) data.
A typical MALDI-TOF-MS data set contains hundreds of spectra, and each
spectrum contains tens of thousands of intensity measurements representing an
unknown number of protein/peptide peaks which are the key features of inter-
est (Hardesty et al., 2011). The data of a single spectrum is usually given in two
columns, with the first column containing the mass-to-charge ratio (m/z) and the
second column containing the corresponding intensity. Before applying this data
directly to the final modeling analysis, it is also important to conduct basic pre-
processing analyses such as baseline correction, denoising, alignment and peak
detection to identify key interested features (Satten et al., 2004; Jeffries, 2005; Re-
nard et al., 2008; Atlas and Datta, 2009; Ndukum et al., 2011). Although these
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basic preprocessing steps may generally extract some peaks for further interest,
there are still hundreds or thousands of retaining potentially important features
which could be used for the subsequent predictive modeling analysis. On the
other hand, the preprocessing procedures should be performed well and carefully
for assuring the precision of feature extraction and quantification, as subsequent
analysis depends on these determinations. It has been shown that the use of i-
nadequate or ineffective methods in the preprocessing steps make it difficult to
extract meaningful biological information from these data (Sorace and Zhan 2003;
Baggerlt et al. 2003, 2004; Yasui et al. 2003a). In this chapter, I have also stud-
ied how to carry out these preprocessing procedures properly and efficiently for
the prediction of patient survival times. Moreover, since the high-dimensionality
of the feature set as well as some high correlations among features, in order to
predict patient survival using a predictive statistical model, one needs to consid-
er dimension reduction and important feature selection in addition to the basic
pre-processing of mass spectrometry (MS) data very carefully.
A number of early attempts, mostly in the genomic data setting, use some ad
hoc dimension reduction methods and incorporate the reduced set of covariates
(e.g., principal components, meta-genes etc.) in a Cox proportional hazards re-
gression model (Pawitan et al., 2004; Bovelstad et al., 2007). In proteomic studies,
dimensionality of the feature set (covariates) is typically even larger comparing
with gene expression data. Recently, penalized regression versions of the Cox
model (Cox, 1972) have been attempted to deal with high dimensional data (Li
and Luan, 2003; Gui and Li, 2005). However, the proportional hazards assumption
of a Cox model itself may be too simplistic for genomic and proteomic applica-
tions. On the other hand, semi-parametric accelerated failure time (AFT) model
with an unspecified error distribution is often regarded as a more flexible alter-
native to the Cox model in survival analysis. As far as I know, there are only a
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few publications about using the AFT model in high dimensional data setting,
which mostly use the microarray platforms. For example, the LASSO (Tibshirani,
1996) and the threshold-gradient-directed regularization along with AFT model
are applied for estimation and variable selection by Huang et al. (2006); predict-
ing survival times using AFT model along with PLS and LASSO is studied by
Datta et al. (2007); the elastic net approach for variable selection under both the
Cox proportional hazards model and the AFT model is adopted by Engler and Li
(2009); Mostajabi et al. (2012) compared the performances of four relatively recent
latent factor and/or penalized regression techniques (PLS, SPLS, LASSO and e-
lastic net) to fit an AFT model based on high dimensional regressors specifically,
to predict patient survival times using high dimensional MS data.
In this chapter, I focused on the two techniques performed best in the study
of Mostajabi et al. (2012), SPLS and elastic net, to fit AFT models for predicting
survival times of patients by using high dimensional MS data. These methods are
then applied to analyze survival times generated from simulated mass spectra,
as well as a real MS data set on advanced non-small cell lung caner (NSCLC)
patients. To ensure the features used in analysis corresponding to real peaks, I
applied a hard thresholding algorithm to remove noise signals from the MS da-
ta. However, under this denoising approach, the intensities under thresholds are
considered as missing data and are usually replaced by zeroes artificially. The
missing data patterns are not independent of the peak intensities of the peptides
and can be considered as left censored data censored at the threshold. There are
generally two basic strategies to dealing with missing values in practice. The sim-
plest strategy is to work only with the complete intensities. That is the data used
for a particular peptide/protein would be based on only the observed peak in-
tensity, and the features containing missing data are excluded from the analysis.
Alternatively, the missing values can be imputed. Tekwe et al. (2012) studied sev-
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eral imputation algorithms. The imputation approach selected should be appro-
priate when the missing values have been censored, as they can result in biased
estimates and statistical inference (Karpievitch et al., 2009). To retain sufficient
true signals meanwhile reduce the bias for the subsequent predictive modeling
analysis, I propose a nonparametric imputation approach based on Kaplan-Meier
estimator by considering the aligned intensities on the selected m/z values across
all spectra as life times. The detailed imputation scheme was explained in Section
4.2.2. I then compare the predictive performance of the patient survival times
with and without the imputation of the left censored peaks. Additionally, I com-
pare different penalized regression schemes along with the AFT models to predict
the patient survival times.
4.2 Method
4.2.1 Preprocessing of MS Data
According to (Antoniadis et al., 2010; Morris et al., 2005), raw spectra acquired
by TOF mass spectrometers are generally a mixture of a real signal, noise of
different characteristics and a varying baseline. Statistically, a possible model for
a given mass spectrum is to represent it schematically by the equation
yi(tj) = Bi(tj) + NiSi(tj) + εij, (4.1)
where yi(tj) represents the observed log spectral intensity for spectrum i at TOF
tj. The true signal Si(t), consists of a sum of possibly overlapping peaks, each cor-
responding to a particular biological molecule, e.g. a protein or a peptide. Bi(tj)
is the baseline representing a relatively smooth artifact commonly seen in mass
spectrometry data, Ni is a constant multiplicative factor to adjust for spectrum-
specific variability, e.g. the possible different amounts of protein in each sample,
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and εij is an additive white noise with variance σ2i arising from the measurement
process. To perform feature extraction and quantification with MALDI-TOF-MS
data, the observed TOFs, tj, j = 1, ..., J will be mapped to a set of inferred mass to
charge ratios (m/z) xj, j = 1, ..., J by calibration. This step aligns multiple spectra
and yields molecular masses that can be used to ascertain the protein identity of a
peak of interest. Eventually, the data of a single spectrum is given in two columns,
with the first column containing the m/z and the second column containing the
corresponding intensity. Low-level preprocessing of the raw MS data are neces-
sary to perform feature extraction and quantification with MALDI-TOF-MS data.
Depending on analysis goals, the preprocessing procedures can be different and
complex in different literatures (Datta et al., 2007; Antoniadis et al., 2010; Morris
et al., 2005; Mostajabi et al., 2012; Ndukum et al., 2011). In our methodology, I
performed three basic preprocessing steps as baseline subtraction, alignment, and
denoising to maintain as much information as possible before applying the AFT
models in the subsequent survival analysis.
In the baseline correction step, the baseline is subtracted from each point and
rescale intensities of all spectra to positive producing a baseline corrected spec-
trum. This step is to remove systematic artifacts, usually attributed to clusters
of ionized matrix molecules hitting the detector during early portions of the ex-
periment, or to detector overload. The relations among raw data, baseline and
processed data of one spectrum are illustrated by Figure 4.1. After baseline cor-
rection of the spectrum data, I apply a binning step to divide the m/z axis into
intervals of desired length, which will help to extract meaningful peak pattern for
alignment. The detailed binning scheme works as following: suppose we set the
binning bandwidth as 0.5Da, we start by rounding all mass to charge values to the
nearest 0.5Da. Then, moving from the lowest rounded m/z value of the spectrum
to the right along the m/z axis, for each rounded m/z values say b, search for the
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maximum intensity y within 0.5Da interval (b− 0.25, b + 0.25). Further, select the
maximum value of the intensity y on the corresponding rounded m/z value (or
alternatively, bin the m/z values to the nearest 0.5Da and average over the inten-
sity values with the same m/z value). To make sure the characteristic features
occur at the same time in all spectra, the subsequent step is to align the spectra
cross samples to make sure that the characteristic features occurs at the same time
in all spectra. Eventually, all the binned spectra data are mapped to a matrix of
common m/z values and the corresponding intensities across samples. The next
step is to denoise the individual spectrum by using a hard threshold h. In hard
thresholding, all intensities less than the threshold are set to zero, while all inten-
sities no less than the threshold remain unchanged (Datta et al., 2007; Mostajabi
et al., 2012; Ndukum et al., 2011). As the noise signals are usually assumed to
be normally distributed, by referring the denoising scheme in Morris et al. (2005);
Antoniadis et al. (2010), I propose to estimate the hard threshold for each spec-
trum as the median absolute deviation (MAD) of its raw intensities divided by






i (xj) ≥ MAD(yi)/0.67;
0, otherwise.
(4.2)
The principle is based on keeping features with intensities greater than a certain
threshold. The threshold should be large enough to eliminate initial noisy region
but small enough to retain any peak that could correspond to real observable
proteins or peptides.
4.2.2 Imputation of Denoised MS Data
After the denoising process with hard thresholds, intensity values that are less
than the noise level are replaced by zeroes in each spectrum. We can extract the
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Figure 4.1: An example of baseline corrected spectra sample (Intensity vs M/Z
value).
key interesting features for survival analysis by selecting the m/z’s corresponding
to more than a specified number of nonzero intensities across all samples. The
selected intensity vectors are considered as covariates for the predicting models in
the following procedure (Mostajabi et al., 2012). On the other hand, we may also
want to maintain as many features as possible, and leave the AFT model to select
the correlated features for survival prediction automatically. To reduce the bias
caused by the zeroes induced in the denoising step, I proposed a nonparametric
imputation method to impute the denoised value by its expected value given that
the noise level of the spectrum was larger than the unobserved true signal.
In the proposed imputation algorithm, first for i = 1, ..., n, we have n spectra
with n cutoffs of noise levels h = (h1, ..., hn). After alignment, we have J selected
m/z values on each spectrum. let X denote a variable for the intensities aligned
on a selected m/z value across all spectra. Let T denote the variable of intensities
in X that are larger than the noise levels h, and E denote the variable of intensities
in X that are lower than h. In the denoising step, all values in E are replaced
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by zeroes. However, If we consider X as a life time variable, X is therefore left
censored with the values in E censored at the noised levels h respectively. By
replacing each value in E with its expected value based on T = {max(h, X); δ =
I(h ≤ X))}, we can apply the AFT model to automatically select key related
features for predicting patient survival times with reduced bias.
The detailed imputation process is as following: for each fixed j, the data is
Tij = {max(hi, Xij); δ = I(hi ≤ Xij)}, for i = 1, ..., n. The variable Tj can therefore
be considered as a left censored life time variable. It is much easier to apply the
Kaplan-Meier estimator to right censored variable compared with left censored
one, therefore we apply a flipping approach to Tj such that T′j = max(Tj)− Tj +
(max(Tj) −min(Tj)). The flipped data is then T′ij = {min(h′i, X′ij); δ′ = I(h′i ≥
X′ij)}, for i = 1, ..., n. When Tj is left censored, its flipped variable T′j is right
censored, and the survival function of T′j becomes the cumulative distribution
function (percentiles) of the original data Tj (Helsel and Lee, 2006).
Given a fixed j, after flipping Tj to T′j , we can then compute the survival
function for T′j by the Kaplan-Meier estimator. Suppose the survival function of
T′j = {min(h′, X′j); δ′ = I(h′ ≥ X′j)} is denoted as S(t). Under the assumption that
T′j is independent of X
′









where τ(1j), ...., τ(mj) are the distinct ordered life time, ∆Nc(τij) is the number of
observations at time τ(ij), and R(τij) = Number of {k : Tckj ≥ τij}, counts the
number of individuals at risk of failing just before time τ(ij).
The censored values can then be imputed from the survival distribution of T′j .
In detail, for the jth covariate X′j, we keep the observed X
′
ij intact; replace each of




larger than the censored time h′i. It can be estimated from the Kaplan-Meier curve
of the survival function of T′j as
X
′∗
ij = {Ŝ(h′i)}−1 ∑
τij>h′i
T′ij∆Ŝ(τij),
where Ŝ is the Kaplan-Meier estimator of the survival function of T′j , and ∆Ŝ(τij) is
the jump size of Ŝ at time τij. Note that for this calculation, the largest event time
τm is treated as a true failure no matter if δm = 0 or not. The further explanation
of this approach can be found in (Datta et al., 2007; Datta, 2005). The estimated
conditional expectation X
′∗
ij is then flipped back to X
∗
ij under the original scale.
Thus, under this imputation approach, we let X̃j = Xj, if δi = 1, and X̃j = X∗j , if
δi = 0. Then the AFT model with SPLS and Enet can be used to fit the imputed
MS data set on the log-transformed patient survival times, respectively.
4.2.3 Survival Prediction Models
The AFT model is presented as logT = XTβ + ε, where β is an unknown
p × 1 parameter of interest associated with the proteomic features X and ε is
an unobservable random error term that is assumed to be independent of X.
Each identified protein feature will be examined as an independent covariate.
The association of each feature with patient survival or time-to-recurrence will
be evaluated. The latent factor and regularization techniques for fitting the AFT
model of Y = logT (logarithm of the patient survival time) on the proteomic
features X (intensity data corresponding to selected m/z values) of patients are
selected by the SPLS and elastic net methods.
The sparse partial least squares regression (SPLS) (Chun and Keleş, 2010) is an
extension of partial least squares regression (PLS) (Wold, 1985) to achieve simul-
taneous dimension reduction and variable selection. PLS extracts latent factors or
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linear combinations of the original regressors that account for most of the varia-
tion in the response while avoiding over-fitting. PLS has become a very popular
tool in the field of chemometrics and bioinformatics (Datta, 2001; Pihur et al.,
2008). SPLS combines the latent factor approach with regularization to obtain
good performance in prediction and variable selection by producing sparse linear
combinations XβT of the original predictors X. This technique achieves the spar-
sity of the coefficients on X by adding the L1 constraints on β, and is especially
applicable when p is much greater than n (Chun and Keleş, 2010).
The elastic net (ENet) (Zou and Hastie, 2005) is a widely applied regularization
and variable selection method. The ENet estimator is obtained by undoing the
shrinkage for the naïve elastic net estimator that is obtained by minimizing the
penalized least squares






(yi − β0 − xTi β)2 + λPα(β), (4.4)
where














Here Pα is the elastic net penalty that is a compromise between the ridge regres-
sion penalty (α = 0) (Hoerl and Kennard, 1970) and the LASSO penalty (α = 1)
(Tibshirani, 1996). The elastic net penalty with α = 1− ε, for some small ε > 0,
performs much like the LASSO but removes any degeneracies and wild behavior
caused by extreme correlations (Friedman et al., 2010). For a given λ, as α increas-
es from 0 to 1, the sparsity of the solution to (4.4), i.e., the number of coefficients
being zero, increases monotonically from 0 to the sparsity of the LASSO solution.
The ENet penalty is particularly useful in the cases that p is greater than n and
there are many correlated predictors (Zou and Hastie, 2005).
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4.3 Simulation
Using the tool developed by Coombes et al. (2005) for simulating realistic mass
spectra, Morris et al. (2005) simulated hundreds of proteomic data sets. The list
of corresponding true peaks (features) is also available. There are 100 data sets
from this collection each containing 100 spectra. We select the first data set for
our simulation. The R package pkDACLASS (Ndukum et al., 2011) was used
for the preprocessing steps explained early. By binning the m/z values to the
nearest 1 Da, I identified 11832 potential features across all the 100 spectra for
the subsequent prediction modeling procedure. The corresponding distinct m/z
values are ranged from 941 Da to 24277 Da.
In order to retain the true signals from the denoised spectra to build a predic-
tive model, three different approached are applied for pre-selection of interesting
features in (Mostajabi et al., 2012). To exam the performance of our imputation
technique, we also applied three approaches referring to (Mostajabi et al., 2012).
The corresponding three groups of data sets of features identified from prepro-
cessed MALDI-TOF-MS data are then denoted as: X(1): features with no less than
one nonzero denoised intensities in all spectra. X(2): features with no less than
half of nonzero denoised intensities in all spectra. X(3): features with nonzero
denoised intensities in all spectra. I denote X(4) as the set of same features in
X(1) with zeroes imputed. The first and third approaches were same as applied
in (Mostajabi et al., 2012). I increased the limit number of nonzeros in the second
approach from 5 to 40 compared with in (Mostajabi et al., 2012).
To simulate survival times T, I randomly select 80 spectra from the first data
set. Four different scenarios for the β coefficients are considered in our simula-
tion. These are as follows: (i) β j = exp{−j} for 1 ≤ j ≤ 11832; (ii) β j = 1/j
for 1 ≤ j ≤ 11832; (iii) for 1 ≤ j ≤ 1000, β j = (j mod 5)/10 if j mod 5 > 0,
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otherwise β j = 0.5 and for 1001 ≤ j ≤ 11832, β j = 0; and (iv) β j = 0.1 and
for 1 ≤ j ≤ 11832. Note that (i) and (ii) both represent situations when all the
co-variables have positive but variable effects on survival; however, due to the
exponential nature of the decaying coefficients, only the first few will have a real
effect on survival in scenario (i). Case (iv) denotes an extreme hypothetical sce-
nario when all covariates have the same positive effect on survival. Presumably,
(iii) denotes the most realistic scenario when the collection of covariates contains
a large number of pure noise variables. In each case, the vector of coefficients is
randomly sampled for computational stability. A normal distribution with vari-
ance rσ2 is used for generating the additive errors, where σ2 = βT ∑X β is the
variability in the regression model. The variance-covariance matrix ∑X is a diag-
onal matrix with the diagonals are all set as 1 and the off-diagonals are all 0. r
denotes a noise to signal ratio. Thus, log normally distributed failure times are
considered. To maintain a similar scale of error variance in each scenario, a value
of r = 1 was used for scenarios (i) and (iii), and r = 0.1 was used for scenarios (ii)
and (iv).
For each design choice, I simulated our training data set by sampling 40 spec-
tra at random from the preselected 80 spectra, and the left are used as test data set.
Denote the training response variable as Yti = log T
t
i , for i = 1, ..., 40. Next, de-
note the response variable in the test data set as Yei = log T
e
i , for i = 1, ..., 40,
I calculate the estimated mean squared error of prediction (EMSEP) for test-





i −Yei )2, where Ŷei is the estimated predicting value calculated
by using the fitted model on the ith sample in the test data set. Each of these mea-
sures is computed by averaging these quantities over 50 Monte-Carlo replicates.
From the simulation results in Table 4.1, we can easily see that the proposed
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Table 4.1: Estimated mean squared error of prediction (EMSEP) for the simulated
data. Four simulation scenarios of simulation settings are studied.
Case i Case ii Case iii Case iv
Enet SPLS Enet SPLS Enet SPLS Enet SPLS
X(1) - Zeroes 0.97 1.56 2.66 4.42 1.51 11.01 1.31 2.58
X(2) - Half 0.97 1.51 2.70 4.11 2.03 10.05 1.34 2.95
X(3) - Complete 1.03 1.73 2.77 4.75 1.49 2.18 1.37 2.43
X(4) - Imputed 0.95 1.46 2.66 3.53 1.46 5.59 1.34 2.21
imputation approach (see the row X(4) in Table 4.1) reduced the EMSEP in all
four cases for both Enet and SPLS methods, comparing with inducing zero only
method (see the row X(1) in Table 4.1), except the in Case iv for ENet method.
In case iv, the EMSEP for ENet in all four approaches are quite similar. There is
no significant evidence to show that the pre-selection of interesting features (see
the rows X(1)− X(3) in Table 4.1) improved the survival prediction performance
for both ENet and SPLS in all cases with only one exception (see the row X(3)
under case iii in Table 4.1). All these results showed that a proper imputation
method should be applied to the denoised data so that we can retain as many
interesting features as possible for the predictive modeling. I applied the analysis
approach to Netherlands Non Small Cell Lung Cancer Data in the real case study
(Voortman et al., 2009).
4.4 Netherlands Non Small Cell Lung Cancer Data Study
In this case study, I used the data set reported in Voortman et al. (2009).
MALDI-TOF-MS spectra of serum samples of 27 patients with advanced non-
small cell lung cancer (NSCLC), treated with chemotherapy and Bortezomib were
obtained. Serum spectra of these patients are available at three time points: pre-
treatment (preTx), after two cycles of treatment (post-2) and at the end of treat-
ment (EOT). For each patient, there is an associated progression-free survival
(PFS) recorded in days. No censoring exists in this data. The range of observed
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survival time in this data set is 27 days to 601 days. I take EOT samples along
with PFS values as major information for further analysis. Two samples are ex-
cluded due to missing EOT serum spectrum. Each spectrum consisted features
with mass-to-charge ratio range of 800-4000 Dalton (Da) with the corresponding
intensities. After baseline correction, it is necessary to align spectra so that char-
acteristic features occur at the same time in all spectra. Because peak patterns are
not clear in the data, to effectively select real features, I tried three scenarios by
setting three different binning widths as 0.01 Da, 0.05 Da and 1 Da, separately. In
different binning scenario, the number of features we selected for the regression
modeling, indicated by the number of rounded m/z values are different. I se-
lected the maximum intensities within each pre-specified intervals of m/z values.
Next, I denoised all 25 spectra as described above.
To exam the performance of our imputation technique, I applied two ap-
proaches for feature selection. The corresponding two groups of data sets of
features identified from preprocessed MALDI-TOF-MS data are then denoted as:
X(1): Features with nonzero denoised intensities in all spectra. X(2): Features
with no less than one nonzero denoised intensities in all spectra. I denote X(3) as
the set of same features in X(2) with zeroes imputed. The numbers of features se-
lected in each data set under different binning widths were summarized in Table
4.2.
Table 4.2: Number of selected features under different binning widths and feature
selection approaches.
Before Denoising X(2) X(1)
1.0 Da 3214 2757 900
0.5 Da 6427 4716 1474
0.1 Da 32131 15480 3701
In the analysis, I used each of the resulting feature sets X(1), X(2), and X(3),
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respectively, in an AFT model to determine the relationship between progression
free survival time (in days) and proteomic features for the 25 cancer samples. As
mentioned before, two methods of modeling fitting SPLS and elastic net are im-
plemented with each feature set. I compared the performance of these methods
by computing their estimated mean squared error of prediction (EMSEP) which is
minimized with respect to the selected values of the tuning (operational) parame-
ters in a regression method. The EMSEP here is computed by leave-one out cross
validation, EMSEP= 1n ∑
n
i=1(Ŷ−i − Yi)2, where Ŷ−i is calculated by first fitting the
model on the sample values other than the ith sample unit and predicting the ith
value using the fitted model with the covariate Xi. SPLS regression has two key
tuning parameters: the thresholding parameter (λ) and number of components
(K). Following the guidelines given in Chun and Keles (2010), cross validation
is computed over the grid of K = 1, 2, ..., 20 and λ = 0.1, 0.2, ..., 0.9. There are
two tuning parameters in the elastic net as well. These are the penalty terms λ1
and λ2. I used the ’glmnet’ R-package in the programming, and let the built-in
cross validation function to decide the optimal tuning parameters automatically.
LASSO is a special case of the elastic net with λ2 = 0.
Table 4.3: Estimated mean squared error of prediction (EMSEP) for the Nether-
land NSCLC data. Three feature selection methods are tested; Under three dif-
ferent binning width 1.0 Da, 0.5 Da and 0.1 Da, X(1) has 900, 1474, 3701 features
and X(2) has 2757, 4716, 15480 features. In each case, the minimum EMSEP value
over the operational parameters is reported for each regression method.
Elastic net SPLS
1 Da 0.5 Da 0.1 Da 1 Da 0.5 Da 0.1 Da
Denoised 0.5256 0.5028 0.4885 0.6678 0.6357 0.6158
Complete 0.4957 0.4975 0.5116 0.8066 0.6233 0.7166
Imputed 0.3818 0.4172 0.4412 0.5230 0.6858 0.6949
Table 4.3 showed the measure of prediction for Netherland NSCLC data. For
both SPLS and elastic net methods, the obtained prediction errors were getting
smaller as the increase of width of binning (as the decrease of number of fea-
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tures selected as showed in Table 4.2). Comparing SPLS and Elastic net, the later
method performs better in all nine cases. For all Elastic net cases, the prediction
errors from imputed data sets are smaller than other two data sets. Similar result
showed for SPLS method, when the binning width is 1 Da. This showed that our
imputation approach advanced the prediction performance for both two methods.
4.5 Discussion and Conclusions
The methods Elastic net and SPLS showed promise in predicting survival with
properly preprocessed mass spectrometry data having large number of features
versus limited sample size. Our simulation study confirmed the benefit of treating
the intensity values under the noise levels as left-censored data, and the non-
parametric imputation method we proposed based on Kaplan-Meier estimator
effectively improved the performance of the prediction models.
It is not the primary purpose of this topic to identify the features and the
corresponding proteins used for survival prediction. However, a further study
in this direction can be conducted in the future research. Moreover, to explore
the full effect of all preprocessing of MS data and feature selection strategies on
survival prediction is beyond the scope of this article.
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Appendix A Specification of Penalty Matrix D
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(4.6)




































































































dz = a1 + a2 + a3. (4.7)













































































j+1dz = a1 + a2. (4.8)






































According to above calculations, we can construct the algorithm to form the
matrix D as following:
For j = 1, ..., K + 1, calculate the matrix aj,1, aj,2, aj,3 and aj,4 according to (4.6).
Set D(j, l) = 0 for all j, l = 1, ..., K + 1.
For j = 1, ..., K + 1,
set D(j, j) according to (4.7),
set D(j, j + 1) and D(j + 1, j) according to (4.8), if j + 1 ≤ K + 1,
set D(j, j + 2) and D(j + 2, j) according to (4.9), if j + 2 ≤ K + 1.
Appendix B Bootstrap Standard Error of g(d1, d2)
The standard error for ĝ(d1, d2) can be obtained via bootstrap. The detailed
procedure is summarized as following:
Step 1. Fit the model based on the original observations, obtain the estimates α̂
for α, and β̂ for β.
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Step 2. Obtain the residuals from the final estimate of f (∗), i.e. εi = yi − f̂ (z) =
yi −∑K−1j=−1 β̂ j I3j (xTi α̂), i = 1, ..., n.




i α̂) + ε
∗
i , i =
1, ..., n, where {ε∗1 , ..., ε∗n} is a random sample from the residuals obtained
in step 2.
Step 4. Fit the model using the generated data, and then obtain the estimated α̂
and ĝ(d1, d2).
Step 5. Repeat step 2 to step 4 B (say, 100) times.
If we denote the estimated g(d1, d2) in the bth (b = 1, ..., B) iteration as g∗b(d1, d2),










(g∗b(d1, d2)− ĝ(d1, d2))2
)
,
thus a 100(1− α)% pointwise confidence interval for g(d1, d2) can be constructed
as
[
ĝ(d1, d2)− zα/2 × ŜD
∗B





where zα/2 is the upper α2 × 100% percentile of the standard normal distribution,
and ĝ(d1, d2) is the estimate for g(d1, d2). Our case study in Section 5 showed that
the estimated variance for g(d1, d2) can account for the carry-over errors from
estimating the marginal dose-effect curves. Our simulations given in Section 4








Ph.D. Biostatistics, University of Louisville (UofL), Louisville, KY, August
2014 (expected)
Thesis title: Penalized regressions for variable selection model, single index
model and survival prediction model
Supervisors: Dr. Maiying Kong and Dr. Susmita Datta
M.S. Mathematics, University of Texas-Pan American (UTPA), Edinburg, TX,
May, 2009
Thesis title: Reaction-diffusion systems with a nonlinear rate of growth
Supervisor: Dr. Zhaosheng Feng
B.S. Mathematics and Applied Mathematics, China University of Mining
and Technology (CUMT), Xuzhou, Jiangsu, China, July, 2007
PROFESSIONAL EXPERIENCE
Graduate Research Assistant Department of Bioinformatics and Biostatistics,
UofL, Louisville, KY, 08/2010 – Present
80
Assisted in an NIH/NHLBI grant supported project CAESAR for study de-
sign, data analysis, and interpretation of statistical results. I have gathered
significant experience in Collecting and cleaning experimental data from
multiple centers, developing suitable data format for statistical analysis,
conducting statistical analysis by using R, SAS and Excel and preparing
analysis reports with summary tables and figures.
Developed monotonic single-index models utilizing penalized regression
splines to assess drug interaction effectively.
Developed survival prediction models with high-throughput Mass Spec-
trometry data for proteomic profiling of important protein signatures.
Developed a weighted elastic net method for variable selection and predic-
tion with missing data, and applied to examine the correlated predictors
for the endothelial function in an ex-vivo experiment successfully.
Developed and implemented self-designed algorithms for all above meth-
ods using R, and conducted numerical simulations to examine the perfor-
mance of each method.
Assisted in providing consulting service to a clinical research team at the
School of Medicine, UofL. Developed linear/nonlinear mixed-effect mod-
els for analyzing effective gene factors in warfarin metabolism with LC-MS
data provided by the collaborators.
Department of Computer Science, UTPA, Edinburg, TX, 08/2009 – 08/2010
Advanced a probabilistic model and algorithm for haplotype construction
from incomplete or inconsistent sequences of haplotype fragments.
Quality Enhancement Plan (QEP) Project Assistant Department of Mathe-
matics, UTPA, Edinburg, TX, 08/2008 – 05/2009
81
Conducted statistical analysis on QEP data from student survey by using
SPSS.
Prepared analysis reports to project coordinator and administrator regular-
ly.
Graduate Teaching Assistant (Lecturer) Department of Mathematics, UTPA,
Edinburg, TX, 08/2007 – 08/2009
Independently lectured seven sections of undergraduate level courses Ele-
mentary and Intermediate Algebra and College Algebra.
PUBLICATIONS
Journal Articles
Z. Feng, Y. Wan. Linearizing Transformations to a Generalized Reaction-
diffusion System, 2010, Applicable Analysis Vol. 89, No. 7, July 2010, 1005–1021.
Y. Wan, S. Datta, D. J. Conklin, M. Kong. Variable Selection Models Based
on Multiple Imputation with an Application for Predicting Median Effective
Dose and Maximum Effect. Accepted by the Journal of Statistical Computation
and Simulation.
Y. Wan, M. Kong., S. Datta (in preparation). Monotonic Single Index Models
with an Application to Assessing Drug Interaction.
Y. Wan, S. Datta, M. Kong (in preparation). Survival Prediction Models for
Proteomic Profiling of Protein Signatures using Mass Spectrometry Data.
Book Chapters
L. Ding, B. Fu, Y. Fu, Y. Wan. Application of Width-Bounded Separators to
Protein Side Chain Packing Problem, Sequence and Genome Analysis: Meth-
ods and Applications, ISBN: 978-0-9807330-4-4, 2010.
82
CONFERENCE PRESENTATIONS
Z. Feng, Y. Wan (May 7-9, 2009). Reaction-diffusion Systems with A Nonlin-
ear Rate of Growth, 8th Mississippi State - UAB Conference on Differential
Equations & Computational Simulations, Department of Mathematics and S-
tatistics, Mississippi State University Mississippi State, MS, USA.
Y. Wan, S. Datta, D. J. Conklin, M. Kong (June 2-5, 2013). Extended Variable S-
election Models for Missing Data with Application to Predict Median Effective
Dose and Maximum Effect, Southern Regional Council on Statistics Summer
Research Conference, Montgomery Bell State Park in Burns, TN, USA.
Y. Wan, S. Datta, D. J. Conklin, M. Kong (June 10-12, 2013). Extended Variable
Selection Models for Missing Data with Application to Predict Median Effec-
tive Dose and Maximum Effect, 2nd International Conference and Exhibition
on Biometrics & Biostatistics, Chicago/Northbrook, IL, USA.
Y. Wan, S. Datta, D. J. Conklin, M. Kong (October 16, 2013). Variable Selec-
tion Models Based on Multiple Imputation with an Application for Predicting
Median Effective Dose and Maximum Effect, ASA Kentucky Chapter Meeting,
Louisville, KY, USA.
SKILLS
Strong knowledge of R, Mathemati-
ca, SPSS, C++, Windows office and
Latex;
Basic knowledge of SAS, JAVA, Mat-
lab, MySQL and Unix Shell
Expert in statistical inference and
consulting, modeling and program-
ming, data mining and analysis;




American Mathematical Society (AMS)
American Statistical Association (ASA)
HONORS & AWARDS
Boyd Harshbarger Student Travel Award, Southern Regional Council on Statis-
tics, American Statistical Association and the National Science Foundation,
06/2013
IMA Travel Support, Department of Mathematics and Statistics, Mississippi
State University, 05/2009
Third Place in HESTC scientific poster competition, UTPA, 09/2008 & 2009
Outstanding Student Award, China University of Mining and Technology,
11/2005 & 2006
REFERENCES
Dr. Maiying Kong, Associate Professor, Department of Bioinformatics and
Biostatistics, University of Louisville, Louisville, KY 40202, Tel: (502) 852-3988,
maiying.kong@louisville.edu
Dr. Susmita Datta, Professor, Graduate Director and University Scholar, De-
partment of Bioinformatics and Biostatistics, University of Louisville, Louisville,
KY 40202, Tel: (502) 852-0081, susmita.datta@louisville.edu
Dr. Zhaosheng Feng, Associate Professor, Department of Mathematics, Uni-
versity of Texas-Pan American, Edinburg, TX 78539, Tel: (956) 665-7483, zs-
feng@utpa.edu
84
